Ara A. Vaporciyan, M.D., F.A.C.S., MHPE

Peer-Reviewed Articles

1. Zhou, N, Bott, M, Park, B, Vallieres, E, Wilshire, CL, Yasufuku, K, Spicer, JD, Jones, DR, Sepesi, B, Mitchell, KG, Corsini, EM, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Huynh, C, Fiset, PO, Chun, SG, Gay, CM. Predictors of survival following surgical resection of limited-stage small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 161(3):760-771.e2, 2021. e-Pub 2021. PMID: 33349449.
2. Cascone T, William WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med 27(3):504-514, 2021. e-Pub 2021. PMID: 33603241.
3. Rajaram R, Abreu JA, Mehran R, Nguyen TC, Antonoff MB, Vaporciyan A. Using Quality Improvement Principles to Redesign a Cardiothoracic Surgery Fellowship Program Website. Ann Thorac Surg 111(3):1079-1085, 2021. e-Pub 2021. PMID: 32745517.
4. Corsini, EM, Hofstetter, WL, Mitchell, KG, Zhou, N, Antonoff, MB, Mehran, RJ, Mena, GE, Rice, DC, Roth, JA, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL. Ketorolac use and anastomotic leak in patients with esophageal cancer. Journal of Thoracic and Cardiovascular Surgery 161(2):448-454, 2021. e-Pub 2021. PMID: 32340809.
5. Parra ER, Zhai J, Tamegnon A, Zhou N, Pandurengan RK, Barreto C, Jiang M, Rice DC, Creasy C, Vaporciyan AA, Hofstetter WL, Tsao AS, Wistuba II, Sepesi B, Haymaker C. Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues. Sci Rep 11(1):4530, 2021. e-Pub 2021. PMID: 33633208.
6. Fajardo R, Vaporciyan A, Starnes S, Erkmen CP. Cardiothoracic surgery wellness: Now and the formidable road ahead. J Thorac Cardiovasc Surg 161(1):333-337, 2021. e-Pub 2020. PMID: 32712002.
7. Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy. Eur J Cardiothorac Surg 59(1):100-108, 2021. e-Pub 2021. PMID: 32864702.
8. Gaudreau PO, Negrao MV, Mitchell KG, Reuben A, Corsini EM, Li J, Karpinets TV, Wang Q, Diao L, Wang J, Federico L, Parra-Cuentas ER, Khairullah R, Behrens C, Correa AM, Gomez D, Little L, Gumbs C, Kadara HN, Fujimoto J, McGrail DJ, Vaporciyan AA, Swisher SG, Walsh G, Antonoff MB, Weissferdt A, Tran H, Roarty E, Haymaker C, Bernatchez C, Zhang J, Futreal PA, Wistuba II, Cascone T, Heymach JV, Sepesi B, Zhang J, Gibbons DL. Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC. J Thorac Oncol 16(1):127-139, 2021. e-Pub 2021. PMID: 33096269.
9. Hu X, Estecio MR, Chen R, Reuben A, Wang L, Fujimoto J, Carrot-Zhang J, McGranahan N, Ying L, Fukuoka J, Chow CW, Pham HHN, Godoy MCB, Carter BW, Behrens C, Zhang J, Antonoff MB, Sepesi B, Lu Y, Pass HI, Kadara H, Scheet P, Vaporciyan AA, Heymach JV, Wistuba II, Lee JJ, Futreal PA, Su D, Issa JJ, Zhang J. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas. Nat Commun 12(1):687, 2021. e-Pub 2021. PMID: 33514726.
10. Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck 43(1):1-6, 2021. e-Pub 2021. PMID: 33169506.
11. Fuller S, Vaporciyan A, Dearani JA, Stulak JM, Romano JC. COVID-19 Disruption in Cardiothoracic Surgical Training: An Opportunity to Enhance Education. Ann Thorac Surg 110(5):1443-1446, 2020. e-Pub 2020. PMID: 32497642.
12. Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi B. Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J Surg Oncol 122(3):495-505, 2020. e-Pub 2020. PMID: 32356321.
13. Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rice DC. Importance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms. J Surg Oncol 122(3):515-522, 2020. e-Pub 2020. PMID: 32468580.
14. Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone T. 18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother 69(8):1519-1534, 2020. e-Pub 2020. PMID: 32300858.
15. Corsini EM, Wang Q, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Reuben A, Vasquez ME, Bernatchez C, Wang J, Cascone T, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi B. Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively. Lung Cancer 146:303-309, 2020. e-Pub 2020. PMID: 32619781.
16. Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SG. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer 21(4):341-348, 2020. e-Pub 2020. PMID: 32279936.
17. Cascone T, Sepesi B, Lin HY, Kalhor N, Parra ER, Jiang M, Godoy MCB, Zhang J, Fossella FV, Tsao AS, Lam VK, Lu C, Mott FE, Simon GR, Antonoff MB, Mehran RJ, Rice DC, Behrens C, Weissferdt A, Moran C, Vaporciyan AA, Lee JJ, Swisher SG, Gibbons DL, Wistuba II, William WN, Heymach JV. A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clin Cancer Res 26(14):3525-3536, 2020. e-Pub 2020. PMID: 32193228.
18. Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. Clin Lung Cancer 21(4):e294-e301, 2020. e-Pub 2020. PMID: 32089476.
19. Ayoub Z, Ning MS, Brooks ED, Kang J, Welsh JW, Chen A, Gandhi S, Heymach JV, Vaporciyan AA, Chang JY. Definitive Management of Presumed Synchronous Early-Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiotherapy. Int J Radiat Oncol Biol Phys 107(2):261-269, 2020. e-Pub 2020. PMID: 32044413.
20. Corsini EM, Datar SS, Mitchell KG, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Blackmon SH, Loree JM, Morris VK, Antonoff MB. High mutational concordance between primary colorectal tumors and associated pulmonary metastases. J Surg Oncol 121(6):984-989, 2020. e-Pub 2020. PMID: 32077113.
21. Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol 38(14):1569-1579, 2020. e-Pub 2020. PMID: 32160096.
22. Mitchell KG, Diao L, Karpinets T, Negrao MV, Tran HT, Parra ER, Corsini EM, Reuben A, Federico L, Bernatchez C, Dejima H, Francisco-Cruz A, Wang J, Antonoff MB, Vaporciyan AA, Swisher SG, Cascone T, Wistuba II, Heymach JV, Gibbons DL, Zhang J, Haymaker CL, Sepesi B. Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort. J Immunother Cancer 8(1), 2020. e-Pub 2020. PMID: 32350118.
23. Awobajo MD, Vaporciyan AA, Lu C, Gandhi SJ. Stereotactic body radiation therapy (SBRT) in the management of pulmonary spindle cell carcinoma. BMJ Case Rep 13(4), 2020. e-Pub 2020. PMID: 32327465.
24. Corsini EM, Mitchell KG, Nguyen TC, Vaporciyan AA, Antonoff MB. Cardiothoracic surgery mock oral examinations: A single institution's 5-year experience. J Thorac Cardiovasc Surg 159(4):1439-1444, 2020. e-Pub 2020. PMID: 31256970.
25. Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus 33(3), 2020. e-Pub 2020. PMID: 31313820.
26. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MB. Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. J Thorac Dis 12(3):184-190, 2020. e-Pub 2020. PMID: 32274083.
27. Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis 12(3):329-337, 2020. e-Pub 2020. PMID: 32274099.
28. Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B. Time Trends of Perioperative Outcomes in Early-Stage Non-Small Cell Lung Cancer Resection Patients. Ann Thorac Surg 109(2):404-411, 2020. e-Pub 2020. PMID: 31539514.
29. Mitchell KG, Negrao MV, Parra ER, Li J, Zhang J, Dejima H, Vaporciyan AA, Swisher SG, Weissferdt A, Antonoff MB, Cascone T, Roarty E, Wistuba II, Heymach JV, Gibbons DL, Zhang J, Sepesi B. Lymphovascular Invasion Is Associated with Mutational Burden and PD-L1 in Resected Lung Cancer. Ann Thorac Surg 109(2):358-366, 2020. e-Pub 2020. PMID: 31550464.
30. Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Improved overall survival with comprehensive local consolidative therapy in synchronous oligometastatic non-small cell lung cancer. Clin Lung Cancer 21(1):37-46.e7, 2020. e-Pub 2020. PMID: 31447303.
31. Pataer A, Ozpolat B, Shao R, Cashman NR, Plotkin SS, Samuel CE, Lin SH, Kabil NN, Wang J, Majidi M, Fang B, Roth JA, Vaporciyan AA, Wistuba II, Hung MC, Swisher SG. Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells. Oncogene 39(4):801-813, 2020. e-Pub 2020. PMID: 31554935.
32. Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. Semin Thorac Cardiovasc Surg 32(2):337-343, 2020. e-Pub 2020. PMID: 31857153.
33. Colson YL, Putnam JB, Yang SC, Fann JI, Vaporciyan AA, Dearani JA, Jones DR, Allen MS, Meyers BF, Wright CD, Shemin RJ, Baumgartner WA, Fullerton DA. The ABTS 10-year Maintenance of Certification Exam Improves and Validates Knowledge Acquisition. Ann Thorac Surg 108(6):1895-1900, 2019. e-Pub 2019. PMID: 31336069.
34. Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL. Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?. Dis Esophagus 32(10):1-6, 2019. e-Pub 2019. PMID: 30888418.
35. Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB. Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations (Phila):1556984519886281. e-Pub 2019. PMID: 31875755.
36. Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer 125(21):3738-3748, 2019. e-Pub 2019. PMID: 31287557.
37. Corsini EM, Luc JGY, Mitchell KG, Turner NS, Vaporciyan AA, Antonoff MB. Predictors of the response of operating room personnel to surgeon behaviors. Surg Today 49(11):927-935, 2019. e-Pub 2019. PMID: 31144105.
38. Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DC. Persistent opioid use is associated with worse survival after lobectomy for stage i non-small cell lung cancer. Pain 160(10):2365-2373, 2019. e-Pub 2019. PMID: 31149979.
39. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy. J Surg Oncol 120(4):729-735, 2019. e-Pub 2019. PMID: 31290159.
40. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation For Siewert II/III Adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
41. Mohammad Z, Mitchell KG, Nelson DB, Robb C, Jreissaty C, Tu J, Vaporciyan AA, Sepesi B, Antonoff MB. Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic. Ann Thorac Surg 108(2):358-362, 2019. e-Pub 2019. PMID: 30928553.
42. Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC. Robotic Assisted Lobectomy For Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg 108(2):370-376, 2019. e-Pub 2019. PMID: 31004583.
43. Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB. Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component. J Thorac Dis 11(8):3391-3398, 2019. e-Pub 2019. PMID: 31559043.
44. Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, Reuben A, Chow CW, McGranahan N, Chen R, Hu J, Godoy MC, Tabata K, Kuroda K, Shi L, Li J, Behrens C, Parra ER, Little LD, Gumbs C, Mao X, Song X, Tippen S, Thornton RL, Kadara H, Scheet P, Roarty E, Ostrin EJ, Wang X, Carter BW, Antonoff MB, Zhang J, Vaporciyan AA, Pass H, Swisher SG, Heymach JV, Lee JJ, Wistuba II, Hong WK, Futreal PA, Su D, Zhang J. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun 10(1):2978, 2019. e-Pub 2019. PMID: 31278276.
45. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg 157(4):1648-1655, 2019. e-Pub 2019. PMID: 30635188.
46. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing. Ann Thorac Surg 107(3):936-940, 2019. e-Pub 2019. PMID: 30612991.
47. Vaporciyan AA. "Crossing the quality chasm" in cardiothoracic surgical education. J Thorac Cardiovasc Surg 157(2):828, 2019. e-Pub 2019. PMID: 30414771.
48. Vaporciyan AA, Yang SC, Fann JI. The young surgeons' page. J Thorac Cardiovasc Surg 157(2):669-670, 2019. e-Pub 2019. PMID: 30448165.
49. Spicer JD, Shewale JB, Nelson DB, Mitchell KG, Bott MJ, Vallieres E, Wilshire CL, Vaporciyan AA, Swisher SG, Jones DR, Darling GE, Sepesi B. Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm. Ann Thorac Surg 107(1):277-284, 2019. e-Pub 2019. PMID: 30227129.
50. Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences between Men and Women. Ann Thorac Surg 106(5):1499-1503, 2018. e-Pub 2018. PMID: 30118712.
51. Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi B. Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series. J Surg Oncol 118(3):518-524, 2018. e-Pub 2018. PMID: 30109699.
52. Vakil E, Sabath B, Baker C, Vaporciyan AA, Casal RF. Bronchocutaneous Fistula without Pneumothorax Localized with Methylene Blue and Managed with Endobronchial Valves. Ann Am Thorac Soc 15(8):992-994, 2018. e-Pub 2018. PMID: 30067094.
53. Luc JGY, Verrier ED, Allen MS, Aloia L, Baker C, Fann JI, Iannettoni MD, Yang SC, Vaporciyan AA, Antonoff MB. Does cramming work? Impact of National Web-Based Thoracic Surgery Curriculum login frequency on thoracic surgery in-training exam performance. J Thorac Cardiovasc Surg 156(2):922-927, 2018. e-Pub 2018. PMID: 29764685.
54. Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Lung Cancer. Ann Thorac Surg 106(1):272-279, 2018. e-Pub 2018. PMID: 29530770.
55. Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer with Ground Glass Components. Ann Thorac Surg 106(1):235-241, 2018. e-Pub 2018. PMID: 29534957.
56. Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg 156(1):406-413.e3, 2018. e-Pub 2018. PMID: 29605441.
57. Liao Z, Lee JJ, Komaki R, Gomez DR, O'Reilly MS, Fossella FV, Blumenschein GR, Heymach JV, Vaporciyan AA, Swisher SG, Allen PK, Choi NC, DeLaney TF, Hahn SM, Cox JD, Lu CS, Mohan R. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 36(18):JCO2017740720, 2018. e-Pub 2018. PMID: 29293386.
58. Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MB. Natural History of Ground Glass Lesions among Patients with Previous Lung Cancer. Ann Thorac Surg 105(6):1671-1677, 2018. e-Pub 2018. PMID: 29432718.
59. Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. J Thorac Cardiovasc Surg 155(6):2635-2645.e15, 2018. e-Pub 2018. PMID: 29548588.
60. Sepesi B, Nelson DB, Mitchell KG, Gibbons DL, Heymach JV, Vaporciyan AA, Swisher SG, Roszik J. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer. Ann Thorac Surg 105(6):1621-1626, 2018. e-Pub 2018. PMID: 29510096.
61. Parra ER, Villalobos P, Behrens C, Jiang M, Pataer A, Swisher SG, William WN, Zhang J, Lee J, Cascone T, Heymach JV, Forget MA, Haymaker C, Bernatchez C, Kalhor N, Weissferdt A, Moran C, Zhang J, Vaporciyan A, Gibbons DL, Sepesi B, Wistuba II. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 6(1):48, 2018. e-Pub 2018. PMID: 29871672.
62. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 53(5):960-966, 2018. e-Pub 2018. PMID: 29211849.
63. Pataer A, Shao R, Correa AM, Behrens C, Roth JA, Vaporciyan AA, Wistuba II, Swisher SG. Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy. Cancer Med. e-Pub 2018. PMID: 29673125.
64. Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang B. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer 124(5):1061-1069, 2018. e-Pub 2018. PMID: 29178133.
65. Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WN. Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer. Ann Thorac Surg 105(2):418-424, 2018. e-Pub 2018. PMID: 29217088.
66. Ontiveros N, Eapen-John D, Osorio N, Song J, Li L, Sheshadri A, Tiang X, Ghosh N, Vaporciyan A, Correa A, Walsh G, Grosu HB, Ost DE. Predicting Lung Function Following Lobectomy: A New Method to Adjust for Inherent Selection Bias. Respiration 96(5):434-445, 2018. e-Pub 2018. PMID: 30257257.
67. Vaporciyan AA, Fikfak V, Lineberry MC, Park YS, Tekian A. Consensus-Derived Coronary Anastomotic Checklist Reveals Significant Variability Among Experts. Ann Thorac Surg 104(6):2087-2092, 2017. e-Pub 2017. PMID: 29074155.
68. Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg 104(6):1821-1828, 2017. e-Pub 2017. PMID: 28987393.
69. Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017. PMID: 28885712.
70. Luc JGY, Nguyen TC, Fowler CS, Eisenberg SB, Wolf RK, Estrera AL, Vaporciyan AA, Antonoff MB. Novel Debate-Style Cardiothoracic Surgery Journal Club: Results of a Pilot Curriculum. Ann Thorac Surg 104(4):1410-1416, 2017. e-Pub 2017. PMID: 28847538.
71. Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi B. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol 35(29):JCO2017738401, 2017. e-Pub 2017. PMID: 28817374.
72. Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, Li H, Mohan R, Heymach JV, Vaporciyan AA, Hahn S, Cox JD. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study. JAMA Oncol 3(8):e172032, 2017. e-Pub 2017. PMID: 28727865.
73. Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J, Dmitrovsky E, Liu X. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer. J Thorac Oncol 12(8):1280-1287, 2017. e-Pub 2017. PMID: 28552766.
74. Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.
75. Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for diaphragmatic reconstruction?. Ann Thorac Surg 17(S0003-4975):30042-5, 2017. e-Pub 2017. PMID: 28366460.
76. Antonoff M, Ragalie W, Sepesi B, Roth J, Walsh G, Hofstetter W, Swisher SG, Rice DC, Vaporciyan AA, Mehran R. Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection. Int J Radiat Oncol Biol Phys 98(1):240, 2017. e-Pub 2017. PMID: 28587019.
77. Sepesi B, Cuentes EP, Canales JR, Behrens C, Correa A, Antonoff M, Gibbons DL, Heymach J, Hofstetter W, Mehran R, Rice DC, Roth J, Vaporciyan AA, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher SG, Wistuba I. Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 98(1):223, 2017. e-Pub 2017. PMID: 28586974.
78. Lopez C, Correa A, Vaporciyan A, Austin M, Rice D, Hayes-Jordan A. Outcomes of chest wall resections in pediatric sarcoma patients. J Pediatr Surg 52(1):109-114, 2017. e-Pub 2017. PMID: 27914587.
79. Yang SC, Vaporciyan AA, Mark RJ, DaRosa DA, Stritter FT, Sullivan ME, Verrier ED. The Joint Council on Thoracic Surgery Education (JCTSE) "Educate the Educators" Faculty Development Course: Analysis of the First 5 Years. Ann Thorac Surg 102(6):2127-2132, 2016. e-Pub 2016. PMID: 27847048.
80. Shi Q, Wang XS, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS. Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer. J Pain Symptom Manage 52(6):822-831, 2016. e-Pub 2016. PMID: 27521528.
81. Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter WB, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Ann Thorac Surg 102(5):1653-1659, 2016. e-Pub 2016. PMID: 27526650.
82. Antonoff MB, Verrier ED, Allen MS, Aloia L, Baker C, Fann JI, Iannettoni MD, Yang SC, Vaporciyan AA. Impact of Moodle-Based Online Curriculum on Thoracic Surgery In-Training Examination Scores. Ann Thorac Surg 102(4):1381-6, 2016. e-Pub 2016. PMID: 27262911.
83. Sepesi B, Rice DC, Heymach JV, Vaporciyan AA, Swisher SG. Stage I lung cancer-to operate or to radiate? that is the question. J Thorac Dis 8(9):2324-2327, 2016. e-Pub 2016. PMID: 27746966.
84. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg 102(1):276-81, 2016. e-Pub 2016. PMID: 27083250.
85. Loor G, Doud A, Nguyen TC, Antonoff MB, Morancy JD, Robich MP, Odell DD, Yarboro LT, Vaporciyan AA, Roselli E. Development and Evaluation of a Three-Dimensional Multistation Cardiovascular Simulator. Ann Thorac Surg 102(1):62-8, 2016. e-Pub 2016. PMID: 27021029.
86. Chu D, Vaporciyan AA, Iannettoni MD, Ikonomidis JS, Odell DD, Shemin RJ, Starnes SL, Stein W, Badhwar V. Are There Gaps in Current Thoracic Surgery Residency Training Programs?. Ann Thorac Surg 101(6):2350-5, 2016. e-Pub 2016. PMID: 27085196.
87. Di Guilmi J, Salvo G, Mehran R, Sood AK, Coleman RL, Lu KH, Vaporciyan A, Ramirez PT. Role of Video-Assisted Thoracoscopy in Advanced Ovarian Cancer: A Literature Review. Int J Gynecol Cancer 26(4):801-6, 2016. e-Pub 2016. PMID: 26937753.
88. Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Survival in Patients with Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg 101(3):1075-81, 2016. e-Pub 2016. PMID: 26680311.
89. Vaporciyan AA. Teaching and Learning Surgical Skill. Ann Thorac Surg 101(1):12-4, 2016. e-Pub 2016. PMID: 26694260.
90. Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer. Ann Thorac Surg 101(1):211-7, 2016. e-Pub 2016. PMID: 26279367.
91. Antonoff MB, Nguyen TC, Luc JGY, Fowler CS, Becker AA, Eisenberg SB, Wolf RK, Estera AL, Vaporciyan AA. A structured, debate-style cardiothoracic surgery journal club for trainee acquisition and application of seminal literature. MedEdPORTAL 12:10521, 2016. e-Pub 2016.
92. Hofstetter W, Vaporciyan A. Invited Commentary. Ann Thorac Surg 100(6):2024-5, 2015. e-Pub 2015. PMID: 26652513.
93. Mokadam NA, Lee R, Vaporciyan AA, Walker JD, Cerfolio RJ, Hermsen JL, Baker CJ, Mark R, Aloia L, Enter DH, Carpenter AJ, Moon MR, Verrier ED, Fann JI. Gamification in thoracic surgical education: Using competition to fuel performance. J Thorac Cardiovasc Surg 150(5):1052-8, 2015. e-Pub 2015. PMID: 26318012.
94. Rice D, Sepesi B, Heymach J, Swisher S, Vaporciyan A. SABR vs surgery for NSCLC in the media. Lancet Oncol 16(9):e422, 2015. e-Pub 2015. PMID: 26370343.
95. Fagundes CP, Shi Q, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS, Wang XS. Symptom Recovery After Thoracic Surgery: Measuring Patient-Reported Outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg 150(3):613-619.e2, 2015. e-Pub 2015. PMID: 26088408.
96. Ai D, Xu G, Feng L, Yu J, Banchs J, Vaporciyan AA, Cata JP, Consortium OR. Dexmedetomidine Does Not Reduce Atrial Fibrillation After Lung Cancer Surgery. J Cardiothorac Vasc Anesth 29(2):396-401, 2015. e-Pub 2015. PMID: 25440618.
97. Munden RF, O'Sullivan PJ, Liu P, Vaporciyan AA. Radiographic evaluation of the pleural fluid accumulation rate after pneumonectomy. Clin Imaging 39(2):247-50, 2015. e-Pub 2015. PMID: 25467424.
98. Vaporciyan AA. 50th Anniversary Landmark Commentary on Mountain CF. Assessment of the role of surgery for control of lung cancer. Ann Thorac Surg 1977;24:365-73. Ann Thorac Surg 99(2):385, 2015. e-Pub 2015. PMID: 25639387.
99. Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management. Ann Thorac Surg 99(2):414-20, 2015. e-Pub 2015. PMID: 25497068.
100. Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang B. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett 357(1):179-85, 2015. e-Pub 2015. PMID: 25444907.
101. Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. Telomere length and recurrence risk after curative resection in patients with early-stage non-small cell lung cancer: a prospective cohort study. J Thorac Oncol 10(2):302-8, 2015. e-Pub 2015. PMID: 25299235.
102. Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Sci Rep 5:12068, 2015. e-Pub 2015. PMID: 26165383.
103. Ikoma N, Vaporciyan A. Sternal metastasis of renal cell carcinoma: The role of metastasectomy. J Thorac Cardiovasc Surg 148(5):e230-1, 2014. e-Pub 2014. PMID: 25152477.
104. Abel EJ, Carrasco A, Karam J, Tamboli P, Delacroix S, Vaporciyan AA, Wood CG. Positive vascular wall margins have minimal impact on cancer outcomes in non-metastatic RCC patients with tumor thrombus. BJU Int 114(5):667-73, 2014. e-Pub 2014. PMID: 24128265.
105. Vaporciyan AA. Apples and oranges: Understanding what our trainees need. J Thorac Cardiovasc Surg 148(4):1167-8, 2014. e-Pub 2014. PMID: 25260265.
106. Antonoff MB, Verrier ED, Yang SC, Lin J, DeArmond DT, Allen MS, Varghese TK, Sengewald D, Vaporciyan AA. Online learning in thoracic surgical training: promising results of multi-institutional pilot study. Ann Thorac Surg 98(3):1057-63, 2014. e-Pub 2014. PMID: 25085560.
107. Subbiah IM, Blackmon SH, Correa AM, Kee B, Vaporciyan AA, Swisher SG, Eng C. Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma. Oncotarget 5(16):6584-93, 2014. e-Pub 2014. PMID: 25051371.
108. Stephens N, Rice D, Correa A, Hoffstetter W, Mehran R, Roth J, Walsh G, Vaporciyan A, Swisher S. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases. Eur J Cardiothorac Surg. e-Pub 2014. PMID: 24603446.
109. Reddy RM, Kim AW, Cooke DT, Yang SC, Vaporciyan A, Higgins RS. The Looking to the Future Medical Student Program: Recruiting Tomorrow's Leaders. Ann Thorac Surg 97(3):741-3, 2014. e-Pub 2014. PMID: 24580895.
110. Vaporciyan AA. Commentary: integrated surgical residency initiative: implications for cardiothoracic surgery. Semin Thorac Cardiovasc Surg 26(1):24-5, 2014. e-Pub 2014. PMID: 24952754.
111. Shen MC, Massarweh NN, Lari SA, Vaporciyan AA, Selber JC, Mittendorf EA, MacGregor MC, Smith BD, Kuerer HM. Clinical course of breast cancer patients with isolated sternal and full-thickness chest wall recurrences treated with and without radical surgery. Ann Surg Oncol 20(13):4153-60, 2013. e-Pub 2013. PMID: 23959054.
112. Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MS, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SG. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24(11):2844-9, 2013. e-Pub 2013. PMID: 23975663.
113. Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up. Ann Thorac Surg 96(4):1138-45, 2013. e-Pub 2013. PMID: 23810174.
114. Vaporciyan AA, Yang SC, Baker CJ, Fann JI, Verrier ED. Cardiothoracic surgery residency training: Past, present, and future. J Thorac Cardiovasc Surg 146(4):759-67, 2013. e-Pub 2013. PMID: 23870155.
115. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, Cancer Group UOTMAE. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 2013. e-Pub 2013. PMID: 24022442.
116. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg 95(6):1872-7, 2013. e-Pub 2013. PMID: 23643547.
117. Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Predictors for locoregional recurrence for clinical stage III-N2 Non-small Cell Lung Cancer with nodal downstaging after induction chemotherapy and Surgery. Ann Surg Oncol 20(6):1934-40, 2013. e-Pub 2013. PMID: 23263700.
118. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol 24(5):1262-6, 2013. e-Pub 2013. PMID: 23247658.
119. Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol 24(1):67-74, 2013. e-Pub 2013. PMID: 23002278.
120. Cata JP, Chukka V, Wang H, Feng L, Gottumukkala V, Martinez F, Vaporciyan AA. Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study. BMC Anesthesiol 13(1):42, 2013. e-Pub 2013. PMID: 24228905.
121. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 94(6):1802-9, 2012. e-Pub 2012. PMID: 23063195.
122. Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-51, 2012. e-Pub 2012. PMID: 22939861.
123. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged pedicled jejunal interposition for esophageal replacement: A 10-Year experience. Ann Thorac Surg 94(4):1104-11; discussion 1111-3, 2012. e-Pub 2012. PMID: 22939245.
124. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 2012. e-Pub 2012. PMID: 22921233.
125. Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Ann Thorac Surg 94(4):1079-84; discussion 1084-5, 2012. e-Pub 2012. PMID: 22795057.
126. Stephens EH, Cornwell LD, Simpson KH, Chu D, Coselli JS, Holman WL, Vaporciyan AA, Merrill WH, Bakaeen FG. Perceptions and expectations of cardiothoracic residents and attending surgeons. J Surg Res 177(2):e45-52, 2012. e-Pub 2012. PMID: 22531676.
127. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-304. e-Pub 2012. PMID: 22964903.
128. Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. The role of consolidation therapy for stage III Non-Small Cell Lung Cancer with persistent N2 disease after induction chemotherapy. Ann Thorac Surg 94(3):914-20, 2012. e-Pub 2012. PMID: 22819472.
129. Vaporciyan AA. Who will determine the educational needs of our trainees?. J Thorac Cardiovasc Surg 144(3):532-3, 2012. e-Pub 2012. PMID: 22749625.
130. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. e-Pub 2012. PMID: 22831985.
131. Ramlawi B, David EA, Kim MP, Garcia-Morales LJ, Blackmon SH, Rice DC, Vaporciyan AA, Reardon MJ. Contemporary surgical management of cardiac paragangliomas. Ann Thorac Surg 93(6):1972-6, 2012. e-Pub 2012. PMID: 22537533.
132. Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, Research Group TUOTMDALCC. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol. e-Pub 2012. PMID: 22481232.
133. Claiborne PM, Fowler CS, Vaporciyan AA. Follow-up of patients with resected thoracic malignancies. Thorac Surg Clin 22(1):123-31, 2012. e-Pub 2012. PMID: 22108696.
134. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2012. e-Pub 2012. PMID: 22172216.
135. Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clin Cancer Res 18(2):585-92, 2012. e-Pub 2012. PMID: 22252258.
136. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the timing of esophagectomy after chemoradiation affect outcome?. Ann Thorac Surg 93(1):207-12; discussion 212-3, 2012. e-Pub 2012. PMID: 21962263.
137. Pool KL, Munden RF, Vaporciyan A, O'Sullivan PJ. Radiographic imaging features of thoracic complications after pneumonectomy in oncologic patients. Eur J Radiol 81(1):165-72, 2012. e-Pub 2012. PMID: 20888720.
138. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus. e-Pub 2011. PMID: 22150920.
139. Hemmati SH, Correa AM, Walsh GL, Swisher SG, Roth JA, Rice DC, Mehran RJ, Vaporciyan AA. The prognostic factors of chest wall metastasis resection. Eur J Cardiothorac Surg 40(2):328-33, 2011. e-Pub 2011. PMID: 21466960.
140. Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, Curley SA, Mehran RJ, Abdalla EK. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg 213(1):62-9, 2011. e-Pub 2011. PMID: 21700179.
141. Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 212(5):821-6, 2011. e-Pub 2011. PMID: 21435923.
142. Bakaeen FG, Stephens EH, Chu D, Holman WL, Vaporciyan AA, Merrill WH, Grover FL. Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals. J Thorac Cardiovasc Surg 141(5):1107-13, 2011. e-Pub 2011. PMID: 21397273.
143. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: A randomized controlled clinical trial. J Clin Oncol 29(8):994-1000, 2011. e-Pub 2011. PMID: 21282546.
144. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 2010. e-Pub 2010. PMID: 21136578.
145. Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus. e-Pub 2010. PMID: 21040152.
146. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer. e-Pub 2010. PMID: 20960497.
147. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Cancer Group MOTMAE, of Medicine TUORS, Group DF. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 2010. e-Pub 2010. PMID: 20881767.
148. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 2010. e-Pub 2010. PMID: 20732514.
149. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg 90(3):884-90; discussion 890-1, 2010. e-Pub 2010. PMID: 20732513.
150. Vaporciyan A, Reardon MJ. Right heart sarcomas. Methodist Debakey Cardiovasc J 6(3):44-8, 2010. e-Pub 2010. PMID: 20834211.
151. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 2010. e-Pub 2010. PMID: 20609777.
152. Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg 89(6):1797-1803, 1804.e1-3; discussion 1803-4, 2010. e-Pub 2010. PMID: 20494031.
153. Harting MT, Lally KP, Andrassy RJ, Vaporciyan AA, Cox CS, Hayes-Jordan A, Blakely ML. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients. J Cancer Res Clin Oncol 136(4):561-70, 2010. e-Pub 2010. PMID: 19784847.
154. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 2010. e-Pub 2010. PMID: 20143431.
155. Reed CE, Vaporciyan AA, Erikson C, Dill MJ, Carpenter AJ, Guleserian KJ, Merrill WH. Factors dominating choice of surgical specialty. J Am Coll Surg 210(3):319-324, 2010. e-Pub 2010. PMID: 20193895.
156. Booth JH, Bryant R, Vaporciyan A, Morales DL. Complete lung parenchyma-sparing resection of the right main stem bronchus and bronchus intermedius. J Thorac Cardiovasc Surg 139(1):222-4, 2010. e-Pub 2010. PMID: 19660315.
157. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 2009. e-Pub 2009. PMID: 19660349.
158. Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-8, 2009. e-Pub 2009. PMID: 19562780.
159. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 2009. e-Pub 2009. PMID: 19699915.
160. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-8; discussion 868-9, 2009. e-Pub 2009. PMID: 19699913.
161. Kassis E, Vaporciyan AA, Swisher S, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418, 2009. e-Pub 2009. PMID: 19619787.
162. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-1387, 2009. e-Pub 2009. PMID: 19464452.
163. Bakaeen FG, Jaroszewski DE, Rice DC, Walsh GL, Vaporciyan AA, Swisher SS, Benjamin R, Blackmon S, Reardon MJ. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era. J Thorac Cardiovasc Surg 137(6):1454-1460, 2009. e-Pub 2009. PMID: 19464464.
164. Vaporciyan AA, Reed CE, Erikson C, Dill MJ, Carpenter AJ, Guleserian KJ, Merrill W. Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents. J Thorac Cardiovasc Surg 137(5):1054-62, 2009. e-Pub 2009. PMID: 19379966.
165. Vaporciyan AA, Reed CE, Erikson C, Dill MJ, Carpenter AJ, Guleserian KJ, Merrill W. Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents. Ann Thorac Surg 87(5):1351-1359, 2009. e-Pub 2009. PMID: 19379863.
166. Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran C, Singh H, Vaporciyan AA, Reardon M. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87(3):977-984, 2009. e-Pub 2009. PMID: 19231448.
167. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal tumor length is independently associated with long-term survival. Cancer 115(3):508-516, 2009. e-Pub 2009. PMID: 19117343.
168. Cen P, Correa A, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan AA, Ajani JA. Adenocarcinoma of the lower esophagus with barrett's esophagus or without barrett's esophagus: Differences in patients survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 2009. PMID: 19021684.
169. Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979-84, 2008. e-Pub 2008. PMID: 18758299.
170. Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer 112(12):2756-64, 2008. e-Pub 2008. PMID: 18457328.
171. Katz RL, Zaidi TM, Fernandez RL, Zhang J, He W, Acosta C, Daniely M, Madi L, Vargas MA, Dong Q, Jiang XG, Caraway NP, Vaporciyan AA, Roth JA, Spitz MR. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol 21(8):950-60, 2008. e-Pub 2008. PMID: 18500269.
172. Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg 84(3)(3):982-986, 2007. e-Pub 2007. PMID: 17720413.
173. Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 14(4):1305-11, 2007. e-Pub 2007. PMID: 17253104.
174. Bahna P, Hanna HA, Dvorak T, Vaporciyan AA, Chambers M, Raad I. Antiseptic effect of a novel alcohol-free mouthwash: a convenient prophylactic alternative for high-risk patients. Oral Oncol 43(2):159-64, 2007. e-Pub 2007. PMID: 16798063.
175. Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Sarcomatoid Carcinoma of the lung: A predictor of poor prognosis. Ann Thorac Surg 84(3):973-980, 2007. e-Pub 2007. PMID: 17720411.
176. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69(2):350-357, 2007. e-Pub 2007. PMID: 17467922.
177. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-1028, 2007. e-Pub 2007. PMID: 17975494.
178. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-1693, 2007. e-Pub 2007. PMID: 17954086.
179. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC Esophageal Cancer Staging System. Ann Thorac Surg 84(2):365-375, 2007. e-Pub 2007. PMID: 17643602.
180. Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-Matched Analysis of Three Techniques for Intrathoracic Esophagogastric Anastomosis. Ann Thorac Surg 83(5):1805-1813, 2007. e-Pub 2007. PMID: 17462404.
181. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg 82(6):1982-7; discussion 1987-8, 2006. e-Pub 2006. PMID: 17126095.
182. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-74, 2006. e-Pub 2006. PMID: 16874819.
183. Reardon MJ, Malaisrie SC, Walkes JC, Vaporciyan AA, Rice DC, Smythe WR, DeFelice CA, Wojciechowski ZJ. Cardiac autotransplantation for primary cardiac tumors. Ann Thorac Surg 82(2):645-50, 2006. e-Pub 2006. PMID: 16863779.
184. Etzel CJ, Lu M, Merriman K, Liu M, Vaporciyan AA, Spitz MR. An epidemiologic study of early onset lung cancer. Lung Cancer 52(2):129-34, 2006. e-Pub 2006. PMID: 16564601.
185. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-9, 2006. e-Pub 2006. PMID: 16242257.
186. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-8, 2006. e-Pub 2006. PMID: 16353210.
187. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. e-Pub 2006. PMID: 16399296.
188. Bagan P, Barthes FLP, Riquet M, Potaris K, Gregoric ID, Radobancevic B, Vaporciyan AA. Prognosis of lung cancer in heart transplant recipient. Annals of Thoracic Surgery 81:409, 2006. e-Pub 2006.
189. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19:152-7, 2006. e-Pub 2006. PMID: 16722991.
190. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 2005. e-Pub 2005. PMID: 16308005.
191. Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104(11):2365-72, 2005. e-Pub 2005. PMID: 16245310.
192. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80(6):1988-92; discussion 1992-3, 2005. e-Pub 2005. PMID: 16305830.
193. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391-8, 2005. e-Pub 2005. PMID: 16256794.
194. Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. Radiology 237(1):342-7, 2005. e-Pub 2005. PMID: 16183941.
195. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan AA, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-55, 2005. e-Pub 2005. PMID: 16130133.
196. Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242(3):392-9; discussion 399-402, 2005. e-Pub 2005. PMID: 16135925.
197. Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg 129(6):1364-70, 2005. e-Pub 2005. PMID: 15942579.
198. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 2005. e-Pub 2005. PMID: 15849517.
199. Shaw AD, Vaporciyan AA, Wu X, King TM, Spitz MR, Putnam JB, Dickey BF. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg 79(5):1704-10, 2005. e-Pub 2005. PMID: 15854959.
200. Potaris K, Radovancevic B, Thomas CD, Gregoric I, Vaporciyan AA, Riggs SA, Radovancevic R, Vaughn WK, Frazier OH. Lung cancer after heart transplantation: A 17-year experience. Ann Thorac Surg 79(3):980-3, 2005. e-Pub 2005. PMID: 15734418.
201. Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-7; discussionn 391-7, 2005. e-Pub 2005. PMID: 15680801.
202. Barkan, GA, Caraway, NP, Jiang, F, Zaidi, TM, Fernandez, R, Vaporciyan, AA, Morice, R, Zhou, Z, Bekele, BN, Katz, RL. Comparison of molecular abnormalities in bronchial brushings tumor touch preparations. Cancer Cytopathol 105:35-42, 2005. e-Pub 2005.
203. Samartzis D, Marco RA, Benjamin R, Vaporciyan AA, Rhines LD. Multilevel En Bloc spondylectomy and chest wall excision via a simultaneous anterior and posterior approach for ewing sarcoma. Spine 30(7):831-837, 2005. e-Pub 2005. PMID: 15803089.
204. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Walsh GL, Vaporciyan AA, Rice DC, Fukami N, Roth JA, Ajani JA. Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus. Int J Gastrointest Cancer 36(2):69-76, 2005. e-Pub 2005. PMID: 16648656.
205. Jr PJ, Benjamin RS, Rha SJ, Walsh GL, Swisher SG, Vaporciyan AA, Smythe WR, Roth JA. Early results of isolated single lung perfusion for treatment of unresectable sarcomatous metastases. J. Thor. Cardiovasc. Surg:In press, 2005. e-Pub 2005.
206. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484-93, 2004. e-Pub 2004. PMID: 15590179.
207. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-85, 2004. e-Pub 2004. PMID: 15386332.
208. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-66, 2004. e-Pub 2004. PMID: 15233663.
209. Ito I, Saeki T, Mohuiddin I, Saito Y, Branch CD, Vaporciyan AA, Roth JA, Ramesh R. Persistent transgene expression following intravenous administration of a liposomal complex: Role of interleukin-10-mediated immune suppression. Mol Ther 9(3):318-27, 2004. e-Pub 2004. PMID: 15006598.
210. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: Analysis of 2588 patients. J Thorac Cardiovasc Surg 127(3):779-86, 2004. e-Pub 2004. PMID: 15001907.
211. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan AA, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-436, 2004. e-Pub 2004. PMID: 15380576.
212. Ito I, Saeki T, Mohuiddin I, Saito Y, Branch CD, Vaporciyan AA, Roth JA, Ramesh R. Persistent transgene expression following intravenous administration of liposomal complex: role of interleukin-10-mediated immune suppression. Mol Ther 9:318-327, 2004. e-Pub 2004.
213. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Lynch PM, Wu TT, Smythe R, Vaporciyan AA, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100(11):2347-2354, 2004. e-Pub 2004. PMID: 15160337.
214. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: A case-control analysis. Clin Cancer Res 10(1 Pt 1):113-23, 2004. e-Pub 2004. PMID: 14734459.
215. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-22, 2003. e-Pub 2003. PMID: 14630268.
216. Ahamad A, Stevens CW, Smythe WR, Liao Z, Vaporciyan AA, Rice D, Walsh G, Guerrero T, Chang J, Bell B, Komaki R, Forster KM. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9(6):476-84, 2003. e-Pub 2003. PMID: 14740977.
217. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan AA, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J. The risk of second primary tumors after resection of stage I non-small cell lung cancer. Ann Thorac Surg 76(4):1001-7; discussion 1007-8, 2003. e-Pub 2003. PMID: 14529975.
218. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan AA, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):20-2, 2003. e-Pub 2003. PMID: 14569843.
219. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-7, 2003. e-Pub 2003. PMID: 12909224.
220. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, Liao Z, Starkschall G, Forster KM. Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55(3):768-75, 2003. e-Pub 2003. PMID: 12573764.
221. Riedel BJ, Vaporciyan AA. Unusual cause of dyspnea after pneumonectomy. J Cardiothorac Vasc Anesth 17(1):131-3, 2003. e-Pub 2003. PMID: 12635076.
222. Ito I, Began G, Mohiuddin I, Saeki T, Saito Y, Branch CD, Vaporciyan AA, Stephens LC, Yen N, Roth JA, Ramesh R. Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration. Mol Ther 7(3):409-418, 2003. e-Pub 2003. PMID: 12668137.
223. Forster KM, Smythe WR, Starkschall G, Liao Z, Takanaka T, Kelly JF, Vaporciyan AA, Ahamad A, Dong L, Salehpour M, Komaki R, Stevens CW. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 55(3):606-616, 2003. e-Pub 2003. PMID: 12573747.
224. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. e-Pub 2003. PMID: 12538456.
225. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan AA, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol 21(5):327-333, 2003. e-Pub 2003. PMID: 14670538.
226. Stevens CW, Walsh G, Smythe WR, Allen P, Vaporciyan AA, Swisher SG, Roth JA, Komaki R. Lung tumor hypoxia predicts for locoregional spread and poor disease free survival in patients with stage I non-small cell lung cancer. Clin. Cancer Res:Submitted, 2003. e-Pub 2003.
227. Rice D, Sabichi A, Kim HW, Lippman S, Lee JJ, Vaporciyan AA, Smythe WR, Swisher S, Walsh G, Jr PJ, Hong WK, Roth J. The risk of second primary tumors after resection of stage I non-small cell lung cancer. Ann. Thorac. Surg 76:1001-1007, 2003. e-Pub 2003.
228. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Jr, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-84; discussion 384-5, 2002. e-Pub 2002. PMID: 12192324.
229. Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, Smythe R, Roth J. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg 22(1):47-52, 2002. e-Pub 2002. PMID: 12103372.
230. Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher SG, Walsh GL, Nesbitt JC, Jr PJ. Incidence of major pulmonary morbidity after pneumonectomy: Association with timing of smoking cessation. Ann Thorac Surg 73:420-5; discussion 425-6, 2002. e-Pub 2002. PMID: 11845853.
231. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175-83, 2002. e-Pub 2002. PMID: 11782772.
232. Sweeney P, Slaton JW, Munsell M, Carpenter S, Vaporciyan AA, Swanson DA, Wood CG, Pisters L, Dinney CP. An analysis of prognostic factors for patients with renal cancer extending into the vena cava. J. Urol 167:193, 2002. e-Pub 2002.
233. Siegenthaler MP, Pisters KM, Merriman KW, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Smythe WR, Jr PJ. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 71:1105-11; discussion 1111-2, 2001. e-Pub 2001. PMID: 11308144.
234. Smythe WR, Estrera AL, Swisher SG, Merriman KW, Walsh GL, Putnam JB, Jr, Vaporciyan AA, Roth JA. Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Ann Thorac Surg 71(3):962-6, 2001. e-Pub 2001. PMID: 11269481.
235. Ajani JA, Komaki R, Putnan JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan AA, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 92:279-286, 2001. e-Pub 2001.
236. Walsh GL, Davis BM, Swisher SG, Vaporciyan AA, Smythe WR, Willis-Merriman K, Roth JA, Jr PJ. A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg 121:48-60, 2001. e-Pub 2001. PMID: 11135159.
237. Sharma C, Roth JA, Vaporciyan AA. Perfluorocarbon improves adenoviral-mediated transfection of lung cancer cells via cell mediated effects. Clin. Cancer Res 7:3781S-3782S, 2001. e-Pub 2001.
238. Putnam JB, Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord LL. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69(2):369-75, 2000. e-Pub 2000. PMID: 10735665.
239. Komaki R, Roth JA, Walsh GL, Jr PJ, Vaporciyan AA, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int. J. Radiat. Oncol. Biol. Phys 48:347-354, 2000. e-Pub 2000.
240. Swisher SG, DeFord L, Merriman KW, Walsh GL, Smythe R, Vaporciyan AA, Ajani JA, Brown T, Komaki R, Roth JA, Putnam JB. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J. Thorac. Cardiovasc. Surg 119:1126-1132, 2000. e-Pub 2000.
241. Gandhi S, Walsh GL, Komaki R, Gokaslan Z, Jr PJ, Roth JA, Merriman K, Vaporciyan AA, Swisher SG. An aggressive multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion can lead to long-term survival. Ann. Thorac. Surg 68:1778-84, 1999. e-Pub 1999.
242. Vaporciyan AA, Mulligan MS, Warren JS, Barton PA, Miyasaka M, Ward PA. Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J Immunol 155(3):1442-9, 1995. e-Pub 1995. PMID: 7636209.
243. Mulligan MS, Vaporciyan AA, Warner RL, Jones ML, Foreman KE, Miyasaka M, RFrd T, Ward PA. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immunol 154:1350-63, 1995. e-Pub 1995. PMID: 7529801.
244. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94(3):1147-55, 1994. e-Pub 1994. PMID: 7521884.
245. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren, II, Thom SR, Jones ML, Ward PA, Albelda SM. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262:1580-2, 1993. e-Pub 1993. PMID: 8248808.
246. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 151:5666-74, 1993. e-Pub 1993. PMID: 7901280.
247. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA. Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 142:1739-49, 1993. e-Pub 1993. PMID: 7685152.
248. Vaporciyan AA, Ward PA. Enhanced generation of O2- by human neutrophils via a complement iC3b/Mac-1 interaction. Biol Signals 2:126-35, 1993. e-Pub 1993. PMID: 8004151.
249. Vaporciyan AA, Jones ML, Ward PA. Rapid analysis of leukocyte-endothelial adhesion. J Immunol Methods 159:93-100, 1993. e-Pub 1993. PMID: 8445268.
250. Mulligan MS, Wilson GP, Todd RF, Smith CW, Anderson DC, Varani J, Issekutz T, Myasaka M, Tamatani T, Rusche JR, Vaporciyan AA, Ward PA. Role of b1, b2 integrins and ICAM-1 in lung injury following deposition of IgG and IgA immune complexes. Immunol 150:2407-2417, 1993. e-Pub 1993.
251. Dick M II, Vaporciyan AA, Bove EL, Morady F, Scott WA, Bromberge BI, Serwer GA, Bolling SF, Behrendt DM, Rosenthal A. Surgical management of children and young adults with the Wolff-Parkinson-White syndrome. Heart Vessels 4:229-336, 1988. e-Pub 1988.
252. Werns SW, Shea MJ, Vaporciyan AA, Phan S, Abrams GD, Buda AJ, Pitt B, Lucchesi BR. Superoxide dismutase does not cause scar thinning after myocardial infarction. J. Am. Cardiol 9:898-902, 1987. e-Pub 1987.

Invited Articles

1. Kassis E, Vaporciyan AA. Defining N2 disease in non-small cell lung cancer. Thoracic Surgery Clinics 18(4):333-337, 2008. e-Pub 2008.
2. Vaporciyan AA. Getting Cancer information from your doctor. CancerWise, 2007. e-Pub 2007.
3. Yendamuri S, Vaporciyan AA. Mediastinoscopy and mediastinal lymph node dissection for lung cancer. Operative Techniques in General Surgery 8:81-89, 2006. e-Pub 2006.
4. Komaki R, Cox JD, JBJr P, Walsh G, Vaporciyan AA, Liao Z, Stevens C, Fossella FV, Lee JS, Hong WK, Roth JA. The management of superior sulcus tumors. J. Jap. Soc. Ther. Radiol. Oncol 13:131-138, 2001. e-Pub 2001.
5. Ward PA, Mulligan MS, Vaporciyan AA. Endothelial and leukocyticadhesion molecules in the pathogenesis of actue pulmonary injury. Thrombosis and Haemostasis Symposium 70:155-157, 1993. e-Pub 1993.

Review Articles

1. Antonoff MB, Mitzman B, Backhus L, Bradbury ST, Chatterjee S, Cooke DT, Crestanello J, Goldstone AB, Kim KM, Nguyen TC, Romano JC, Vaporciyan AA, Varghese TK. The Society of Thoracic Surgeons (STS) Virtual Conference Taskforce: Recommendations for Hosting a Virtual Surgical Meeting. Ann Thorac Surg 111(1):16-23, 2021. e-Pub 2021. PMID: 33137298.
2. Vaporciyan AA. How to Give Effective Formative Feedback in Thoracic Surgery Education. Thorac Surg Clin 29(3):249-257, 2019. e-Pub 2019. PMID: 31235293.
3. Aloia L, Vaporciyan AA. E-Learning Trends and How to Apply Them to Thoracic Surgery Education. Thorac Surg Clin 29(3):285-290, 2019. e-Pub 2019. PMID: 31235297.
4. Nelson DB, Tam AL, Mitchell KG, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Vaporciyan AA, Hofstetter WL. Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review. Ann Thorac Surg 107(6):1876-1883, 2019. e-Pub 2019. PMID: 30508527.
5. Hoang AN, Vaporciyan AA, Matin SF. Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the literature. J Endourol 24(6):1005-12, 2010. e-Pub 2010. PMID: 20491594.
6. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-60; discussion 1152-60, 2004. e-Pub 2004. PMID: 15464463.
7. Vaporciyan AA, Putnam JB, Smythe WR. The potential role of aprotinin in the perioperative management of malignant tumors. J Am Coll Surg 198(2):266-78, 2004. e-Pub 2004. PMID: 14759785.
8. Maish M, Vaporciyan AA. Chondrosarcoma arising in the trachea: a case report and review of the literature. J Thorac Cardiovasc Surg 126(6):2077-80, 2003. e-Pub 2003. PMID: 14688730.
9. Putnam JB, Royston D, Chambers AF, Dunbar S, Lemmer JH, Norman P, Travis E, Vaporciyan AA, Yang S, Zacharski LR. Evaluating the role of serine protease inhibition in the management of tumor micrometastases. Oncology (Williston Park) 17(10 Suppl 10):9-30; quiz 31-2, 2003. e-Pub 2003. PMID: 14606367.
10. Ward PA, Mulligan MS, Vaporciyan AA. Endothelial and leukocytic adhesion molecules in the pathogenesis of acute pulmonary injury. Thromb Haemost 70:155-7, 1993. e-Pub 1993. PMID: 7901920.

Editorials

1. Vaporciyan AA. Isolated lung perfusion, is it time to deal with the 800 pound gorilla?. J Surg Oncol 96(7):543-544, 2007. PMID: 17999390.
2. Vaporciyan AA, Van S, Weksler B, Korst RJ, Demeester SR, Feins RH. Isolated lung perfusion with melphalan for resectable lung metastases: A phase I clinical trial - Discussion. Ann. Thorac. Surg 78:1926-1927, 2004.
3. Reed CE, Vaporciyan AA, Grover FL, Robers JR. Incidence of major pulmonary morbidity after pneumonectomy: Association with timing of smoking cessation - Discussion. Ann. Thorac. Surg 73:425-426, 2002.

Abstracts

1. Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff, MB. Travel Distance as a Barrier for Surveillance Imaging in Early Staged Lung Cancer. Society of Thoracic Surgery Virtual Annual Meeting, 2021. e-Pub 2021.
2. Farooqi A, Mitchell K, Ludmir E, Boyce-Fappiano D, Vaporciyan AA, Swisher S, Zhang J, Le X, Antonoff M, Gomez D, Elamin Y, Heymach J, Gandhi S. EGFR Mutations Predict Superior Survival of NSCLC Patients with Oligometastatic Disease Treated with Local Consolidative Therapy. 2020 World Conference on Lung Cancer, 2021. e-Pub 2021.
3. Zhou N, Rice D, Mehran R, Feldman H, Tomczak K, Hofstetter W, Vaporciyan A, Correa A, Zhang J, Haymaker C, Tsao A, Sepesi B. Association between Baseline Tumor Thickness and Response to Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma. 2020 World Conference on Lung Cancer, 2021. e-Pub 2021.
4. Bostock IC, Zhou N, Antonoff MB, Blum Murphy M, Lin S, Maru D, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher S, Vaporciyan A, Walsh GL, Wayne Hofstetter WL. Prolonged Neutrophilia is associated with worse outcomes after Esophagectomy. Society for Vascular Surgery, 2021. e-Pub 2021.
5. Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Gandhi S, Gomez D. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer. 2021 World Conference on Lung Cancer, 2021. e-Pub 2021.
6. Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy. 1st Annual Meeting of the European-Society-of-Thoracic-Surgeons (ESTS), 2020. e-Pub 2020.
7. Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Timing And Patterns Of Recurrence In Lung Cancer Patients With Major Pathologic Response Following Neoadjuvant Chemotherapy – The Influence Of Persistent Pathological Nodal Disease. ESTS Virtual Conference 2020, 2020. e-Pub 2020.
8. Datar SS, Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Loree JM, Morris VK. Are Mutational Profiles of Colorectal Cancer And Pulmonary Metastases Concordant?. American College of Surgeons South Texas Chapter Annual Meeting, 2020. e-Pub 2020.
9. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris V, Antonoff MB. Is Laterality of Primary Colorectal Cancer Associated with Survival After Pulmonary Metastasectomy?. American College of Surgeons South Chapter Annual Meeting, 2020. e-Pub 2020.
10. Corsini EM, Mitchell KG, Nguyen TC, Vaporciyan AA, Antonoff MB. The Role Of Mock Oral Examinations In Cardiothoracic Surgery Training. The University of Texas Academy of Health Science Education Annual Meeting, 2020. e-Pub 2020.
11. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Lin SH, Ajani JA, Hofstetter WL. Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation. 56th Annual Meeting of the Society of Thoracic Surgeons, 2020. e-Pub 2020.
12. Datar SS, Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Loree JM, Morris VK, Antonoff MB. High Mutational Concordance Between Next Generation Sequencing Profiles of Colorectal Cancer and Pulmonary Metastases. STSA 2019 (#133), 2019. e-Pub 2019.
13. Corsini EM, Mitchell KG, Mehran RJ, Sepesi B, Wlash GL, Antonoff MB, Rice DC, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL. Endoscopic Biopsy Poorly Identifies Signet Ring Cell Histology in Untreated Esophageal Adenocarcinoma. STSA 2019 (#28), 2019. e-Pub 2019.
14. Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi MA, Stroehlein J, Mehran R, Walsh G, Vaporciyan AA, Swisher S, Hofstetter W. Endoscopic Intrapyloric Botulinum Toxin Injection With Pyloric Balloon Dilation for Delayed Gastric Emptying After Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience. Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), 2019. e-Pub 2019.
15. Sepesi B, Godoy M, William W, Vaporciyan A, Lin H, Lueng C, Lee J, Mitchell K, Weissferdt A, Le X, Lam V, Fossella F, Swisher S, Heymach Cascone T. Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer. Part of Special Issue: IASLC 2019 World Conference on Lung Cancer: Conquering Thoracic Cancers Worldwide, 2019. e-Pub 2019.
16. Sepesi B, Cascone T, William WN, Lin H, Leung CH, Weissferdt A, Walsh GL, Rice D, Roth J, Mehran R, Hofstetter W, Antonoff M, Heymach JV, Gibbons D, Papadimitrakopolou V, Fossella F, Mott F, Le X, Blumenschein G, Vaporciyan AA, Swisher SG. Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab In Non-Small Cell Lung Cancer - NEOSTAR study. WCLC 2019 (#OA13.06), 2019. e-Pub 2019.
17. Gaudreau P, Negrao M, Mitchell K, Corsini E, Karpinets T, Wang Q, Diao L, Wang J, Federico L, Parra E, Li J, Behrens C, Correa A, d G, Vaporciyan A, Weissferdt A, Tran H, Roarty E, Wistuba I, Reuben A, Haymaker C, Bernatches C, Cascone T, Heymach J, Sepesi B, Zhang J, Gibbons D. Neoadjuvant Chemotherapy Is Associated with Immunogenic Cell Death and Increased T Cell Infiltration in Early-Stage NSCLC. IASLC 2019 World Conference on Lung Cancer, 2019. e-Pub 2019.
18. Rocha P, Salazar R, Solorzano J, Zhang J, Mino B, Parra E, Ledesma D, Kadara H, Zhang J, Vaporciyan A, Rice D, Kalhor N, Moran C, Gibbons D, Weissferdt A, Sepesi B, Wistuba I, Behrens C, Solis L. CD73 Expression in Lung Adenocarcinomas and Immunological and Molecular Associations. IASLC 2019 World Conference on Lung Cancer, 2019. e-Pub 2019.
19. Guadreau P, Ajami N, Sepesi B, Karpinets T, Reuben A, Won M, Parra E, Federico L, Gopalakrishnan V, Mitvhell K, Negrao M, Spencer C, Vaporciyan A, Weissferdt A, Haymaker C, Tran H, Bernatchez C, Landry L, Roarty E, Cascone T, Heymach J, Zhang J, Wistuba I, Zhang J, Wardo J, Gibbons D. Depicting the Intra-Tumoral Viral and Microbial Landscape of Localized NSCLC Using Standard Next Generation Sequencing Data. IASLC 2019 World Conference on Lung Cancer, 2019. e-Pub 2019.
20. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris V, Antonoff MB. Primary Colorectal Cancer Laterality Predicts Survival After Pulmonary Metastasectomy. American Association of Thoracic Surgery International Thoracic Surgical Oncology Summit, 2019. e-Pub 2019.
21. Corsini EM, Mitchell KG, Van Haren RM, Mehran RJ, Rice DC, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Vaporciyan AA, Roth JA, Hofstetter WL. Patient-Related Factors Are The Greatest Determinant Of Pulmonary Morbidity Following Lung Cancer Resection In Enhanced Recovery Setting. American Association of Thoracic Surgery International Thoracic Surgical Oncology Summit, 2019. e-Pub 2019.
22. Lin SH, Hobbs B, Thall P, Tidwell RS, Wei X, Komaki RU, Chang JY, Chun SG, Jeter MD, Hahn SM, Swisher SG, Ajani JA, Murphy MB, Vaporciyan AA, Mehran R, Koong AC, Gandhi S, Hofstetter W, Liao Z, Mohan R. Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer. 61st Annual Meeting of the American Society for Radiation Oncology ASTRO, 2019. e-Pub 2019.
23. Reuben A, Zhang J, Gittelman R, Chiou S, Li J, Fujimoto J, Behrens C, Kheradmand F, Chow C, Bernatches C, Eterovic AK, Benjeno S, Vignali M, Wu XXF, Ye Y, Cascone T, Herbst R, Swisher S, Kadara H, Moran C, Zhang J, Scheet P, Vaporciyan A, Sepesi B, Gibbons D, Robins H, Hwu P, Heymach J, Sharma P, Allison J, Lee J, Davis M, Wistuba I, Futreal PA, Zhang J. Increased Frequency of Bystander T Cells in the Lungs Is Associated with Recurrence in Localized Non-Small Cell Lung Cancer. IASCLC 2019 World Conference on Lung Cancer, 2019. e-Pub 2019.
24. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Antonoff MB, Walsh GL, Roth JA, Swisher SG, Vaporciyan AA, Hofstetter WL. Evaluation of Ketorolac Use with Occurrence of Esophageal Anastomotic Leak After Esophagectomy. American Association of Thoracic Surgery International Thoracic Surgical Oncology Summit, 2019. e-Pub 2019.
25. Ayoub Z, Brooks E, Welsh J, Chen A Gandhi S, Heymach J, Vaporciyan A, Chang J. Stereotactic Ablative Radiotherapy in the Management of Synchronous Early Stage Non-Small Cell Lung Cancers. Part of a Special issue: IASLC 2019 World Conference on Lung Cancer: Conquering Thoracic Cancers Worldwide, 2019. e-Pub 2019.
26. Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Pulmonary Resection is Associated with Durable Overall Survival in Synchronous Oligometastatic Non-Small Cell Lung Cancer. AATS International Thoracic Surgery Oncology Summit, 2019. e-Pub 2019.
27. Mitchell KG, Fujimoto J, Chow CW, Parra ER, Federico L, Zhang JH, Vaporciyan AA, Bernatchez C, Cascone T, Sepesi B, Wistuba II, Heymach JV, Zhang JJ, Gibbons DL. Immunogenomic profiling identifies a subgroup of squamous cell lung cancers with immunosuppressed tumor microenvironment and correlates TGF-beta and Wnt/beta-catenin signaling as predictive of low PD-L1 expression. Annual Meeting of the American-Association-for-Cancer-Research (AACR), 2019. e-Pub 2019.
28. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MB. Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. 27th European Conference on General Thoracic Surgery of the European Society of Thoracic Surgeons (ESTS), 2019. e-Pub 2019.
29. Mitchell KG, Diao L, Tran HT, Negrao MV, Karpinets T, Wang J, Cuentas ERP, Corsini EM, Reuben A, Fedrico L, Bernatchez C, Vaporciyan AA, Swisher S, Cascone T, Wistuba II, Heymach J, Zhang JJ, Gibbons DL, Haymaker CL, Sepesi B. Association of relative neutrophilia with a distinct immunoinhibitory milieu in non-small cell lung cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2019. e-Pub 2019.
30. Reuben A, Zhang JJ, Lin HY, Little L, Gumbs C, Tran HT, Wang LH, Haymaker CL, Mehran RJ, Rice DC, Walsh GL, Lee JJ, Wistuba II, Swisher S, Vaporicyan AA, Futreal A, Sepesi B, Heymach J, Gibbons DL, Cascone T. T cell repertoire analysis of non-small cell lung cancer patients treated with neoadjuvant nivolumab alone or in combination with ipilimumab (NEOSTAR trial). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2019. e-Pub 2019.
31. Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. AATS 2019 Annual Meeting, 2019. e-Pub 2019.
32. Nelson DB, Niu J, Mitchel KG, Vaporciyan AA, Hofstetter WL, Antonoff MB, Giordano SH, Sepesi B, Mehran RJ, Rice DC. Readmissions, Morbidity and Early Mortality Among Chronic Opioid Users Who Receive Lobectomy for Non-Small Cell Lung Cancer. AATS 2019 Annual Meeting, 2019. e-Pub 2019.
33. Cascone T, William WN, Weissferdt A, Lin HY, Leung CH, Carter BW, Fossella FV, Mott F, Papadimitrakopoulou V, Blumenschein GR, Le XN, Federico L, Cuentas ERP, Bernatchez C, Wistuba II, Vaporciyan AA, Gibbons DL, Swisher S, Heymach J, Sepesi, B. Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study, 2019. e-Pub 2019.
34. Nelson DB, Niu J, Mitchell KG, Antonoff MB, Giordano SH, Hofstetter WL, Vaporciyan AA, Sepesi B, Mehran R, Rice DC. Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer. 99th Annual Meeting of the American-Association-for-Thoracic-Surgery (AATS), 2019. e-Pub 2019.
35. Le X, Negrao MV, Reuben A, Lee WC, Parra E, Li J, Karpinets T, Behrens C, Sepesi B, Vaporciyan A, Roth J, Haymaker C, Roarty E, Zhang J, Bernatchez C, Zhang J, Wistuba I, Gibbons D, Heymach JV. Characterization of the tumor immune microenvironment in treatment-naïve EGFR-mutant NSCLC uncovers a low IFN-gamma suppressed immune phenotype. AACR 2019 (#5028), 2019. e-Pub 2019.
36. Corsini EM, Mitchell KG, Mehran RJ, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB Rice DC. Outcomes After Resection Of Thymic Neoplasms With Pleural Metastases. GTSC 2019, 2019. e-Pub 2019.
37. Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Vaporciyan AA, Swisher SG, Heymach J, Zhang J, Gomez DR, Antonoff M. Improved Overall Survival with Local Consolidative Therapy in Oligometastatic Non-Small Cell Lung Cancer: Results from a Cohort of 194 Patients with Synchronous Disease. Multidisciplinary Thoracic Cancers Symposium, 2019. e-Pub 2019.
38. Corsini EM, Mitchell KG, Mehran R, Rice DC, Sepesi B, Walsh G, Swisher SG, Roth J, Vaporciyan AA, Hofstetter W, Antonoff M. Multidisciplinary Treatment of Thymic Neuroendocrine Tumors: Evaluation of the Impact of Surgery, Chemotherapy, and Radiation. Multidisciplinary Thoracic Cancers Symposium, 2019. e-Pub 2019.
39. Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Improved oveall survival with local, consolidative therapy in oligometastatic non-small cell lung cancer: Results from cohort of 194 patients with synchronous disease. Multidisciplinary Thoracic Cancer Symposium, 2019. e-Pub 2019.
40. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Antonoff MB. Multidisciplinary Teatment of Thymic Neuroendocring Tumors: Evaluation of Surgery, Chemotherapy, and Radiation. Multidisciplinary Thoracic Cancer Symposium, 2019. e-Pub 2019.
41. Mitchell KG, Negrao M, Parra ER, Reuben A, Vaporciyan AA, Swisher SG, Roth JA, Alvarez de Lacerda Landry LC, Wistuba II, Bernatchez C, Haymaker C, Weissferdt A, Roarty E, Cascone T, Gibbons DL, Heymach JV, Zhang J, Sepesi B, Team I. Clinicopathological and Immune Microenvironment Features Associated with High Tumor Mutational Burden and PD-L1 Expression in Resected Non-Small Cell Lung Cancer. STS 2019, 2019. e-Pub 2019.
42. Nelson DB, Mitchell KG, Wang J, Fujimoto J, Behrans C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune Regulatory Markers of Lepidic-Pattern Adenocarcinomas Presenting as Ground Glass Opacities. STS 2019, 2019. e-Pub 2019.
43. Mitchell KG, Parra ER, Nelson DB, Corsini EM, Zhang J, Vaporciyan AA, Hofstetter WL, Mehran RJ, Swisher SG, Rice DC, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran CA, Skoulidis F, Wistuba II, Fujimoto J, Roth JA, Antonoff MB. Intratumoral LKB1/STK11 Expression Correlates with Immune Cell Infiltration and Oncologic Outcomes Following Resection of Lung Adenocarcinoma. STS 2019, 2019. e-Pub 2019.
44. Nelson DB, Niu J, Mitchell KG, Sepesi B, Vaporciyan AA, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Antonoff MB, Mehran RJ, Rice DC. Persistent Opioid Use Among The Elderly After Lung Resection: A SEER-Medicare Study. STS 2019, 2019. e-Pub 2019.
45. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Primary Colorectal Cancer Mutations Predict Survival and Recurrence After Pulmonary Metastasectomy. STS 2019, 2019. e-Pub 2019.
46. Mitchell KG, Negrao MV, Parra ER, Li J, Zhang, JH, Dejima H, Vaporciyan AA, Swisher SG, Weissferdt A, Antonoff MB, Cascone T, Roarty E, Wistuba II, Heymach, JV, Gibbons DL, Zhang JJ, Sepesi B. Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer. 55th Annual Meeting of the Society-of-Thoracic-Surgeons, 2019. e-Pub 2019.
47. Colson YL, Putnam JB, Yang SC, Fann JI Vaporciyan AA, Dearani JA, Jones DR, Allen MS, Meyers BF, Wright CD, Shemin RJ, Baumgartner WA, Fullerton DA. American Board of Thoracic Surgery 10-Year Maintenance of Certification Exam Improves and Validates Knowledge Acquisition. 55th Annual Meeting of the Society of Thoracic Surgeons, 2019. e-Pub 2019.
48. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Badgwell BD, Hofstetter WL. Predictors Of Mediastinal Involvement After Neoadjuvant Chemoradiation In Adenocarcinoma Of The Gastroesophageal Junction. STSA 2018, 2018. e-Pub 2018.
49. Mitchell KG, Nelson DB, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Antonoff MB. Surveillance Patterns after Treatment of NSCLC with Lobectomy and Stereotactic Body Radiotherapy. STSA 2018, 2018. e-Pub 2018.
50. Federico L, Ravelli A, Haymaker C, Forget MA, Karpinets T, Roszik J, Sakellariou-Thompson D, Kim YU, Bhatta A, Celestino M, Reuben A, Weissferdt A, Vaporciyan AA, Antonoff MB Walsh G, Futreal A, Wistuba I, Roth J, Jianjun Z, Roarty E, de Lacerda-Landry LA, Swisher SG, Cascone T, Lizer GA, Heymach JV, Sepesi B, Gibbons D, Bernatchez C. Poster: CD8+ tumor-infiltrating lymphocytes expanded from a NSCLC immunosuppressive environment display neoantigen-specific recognition. The Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting, 2018. e-Pub 2018.
51. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma. 65th Annual Meeting of the Southern Thoracic Surgical Association,, 2018. e-Pub 2018.
52. Mohammad Z, Mitchell KG, Nelson DB, Robb C, Jreissaty C, Tu J, Vaporciyan AA, Sepesi B, Antonoff MB. Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic. 65th Annual Meeting Southern Thoracic Surgical Association, 2018. e-Pub 2018.
53. Nelson DB, Mehran RJ, Mitchell KG, Van Haren RM, Mena GE, Woodard T, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Heymach JV, Rice DC. Adjuvant Chemotherapy is Facilitated by Enhanced Recovery After Thoracic Surgery. 2018 AATS International Thoracic Surgical Oncology Summit, 2018. e-Pub 2018.
54. Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B. Poster: Defining the Role of Adjuvant Radiotherapy for Malignant Pleural Mesothelioma: A Propensity Matched Landmark Analysis of the national Cancer Data Base. AATS International Thoracic Surgical Oncology Summit 2018, 2018. e-Pub 2018.
55. Nelson DB, Rice DC, Mitchell KG, Hofstetter WL, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Tsao AS, Gomez DR, Sepesi B, Mehran RJ. Poster: Return to Intended Oncologic Treatment (RIOT) After Extrapleural Pneumonectomy or Pleurectomy / Decortication for Malignant Pleural Mesothelioma. AATS International Thoracic Surgical Oncology Summit 2018, 2018. e-Pub 2018.
56. Weissferdt A, Sepesi B, Pataer A, Kalhor N, Moran CA, William WN, Le X, Glisson B, Lu C, Skoulidis F, Blumenschein G, Zhang J, Altan M, Rice D, Mehran R, Vaporciyan A, Gibbons DL, Swisher SG, Heymach JV, Cascone T. Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC). ESMO 2018, 2018. e-Pub 2018.
57. Mohammad ZB, Nelson DB, Lapid D, Correa AM, Mitchell KG, HofstetterWL, Mehran RJ, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Rice DC, Antonoff MB. Sex-Related Outcomes after Lobectomy for Stage I Non-Small Cell Lung Cancer: A Single Institution Experience. AATS International Thoracic Oncology Summit, 2018. e-Pub 2018.
58. Mitchell KG, Parra ER, Nelson DB, Vaporciyan AA, Hofstetter WL, Mehran RJ, Swisher SG, Rice DC, Sepesi B, Walsh GL, Zhang J, Behrens C, Kalhor N, Weissferdt A, Moran CA, Wistuba II, Fujimoto J, Roth JA, Antonoff MB. Tumor cellular proliferation correlates with immune checkpoint expression and lymphocyte infiltration in resected non-small cell lung cancer (NSCLC). AATS International Thoracic Surgical Oncology Summit, 2018. e-Pub 2018.
59. Wistuba II, Salazar R, Solorzano JL, Solis L, Behrens C, Mino B, Parra ER, Zhang J, Vaporciyan AA, Rice DC, Kalhor N, Moran C, Gibbons DL, Weissferdt A, Sepesi B. CD73 Immunohistochemical Expression In Malignant Cells And Correlation With Immune Infiltrate in Non-Small Cell Lung Carcinoma (NSCLC). 2018 IASLC 19th World Conference on Lung Cancer, 2018. e-Pub 2018.
60. Lam VK, Tran HT, Vasquez ME, Li K, Yuen K, Vang F, Jaimovich A, Kennedy D, Odegaard J, Mortimer S, Olsen SR, Raymond VM, Vaporciyan AA, Antonoff MB, Walsh GL, Roarty E, Lacerda L, Roth JA, Swisher S, Bernatchez C, Sepesi B, Gibbons DL, Zhang J, Heymach JV. Circulating Tumor DNA Analysis with a Novel Variant Classifier for Recurrence Detection in Resected, Early-Stage Lung Cancer. WCLC 2018, 2018. e-Pub 2018.
61. Weissferdt A, Cascone T, Pataer A, Kalhor N, Moran C, Antonoff MB, Walsh GL, Bernatchez C, Gibbons DL, Wistuba II, Roth JA, Zhang J, Roarty E, Landry L, Vaporciyan AA, Heymach JV, Swisher S, Sepesi B. Histopathologic parameters define features of treatment response to neoadjuvant chemotherapy in non-small cell lung cancer. WCLC 2018, 2018. e-Pub 2018.
62. Sepesi B, Federico L, Mitchell KG, Parra E, Cruz AF, Ravelli A, Haymaker C, Karpinets T, Cascone T, Weissferdt A, Antonoff MB, Walsh GL, Bernatchez C, Roth JA, Zhang J, Roarty E, Landry LC, Vaporciyan AA, Swisher S, Heymach JV, Wistuba II, Gibbons DL. PD-L1 Expression is Predominant in CD68+ Tumor-Associated Macrophages in Stage I-III Non-Small Cell Lung Cancers. WCLC 2018, 2018. e-Pub 2018.
63. Cascone T, Sepesi B, Lin HY, Kalhor N, Zhang J, Fossella FV, Tsao AS, Lam VK, Lu C, Mott F, Simon GR, Antonoff M, Mehran RJ, Rice DC, Vaporciyan AA, Godoy M, Lee JJ, Swisher S, William WN, Heymach J. A phase I study of neoadjuvant cisplatin (C), docetaxel (D) and nintedanib (N) for resectable non-small cell lung cancer (NSCLC). ASCO 2018, 2018. e-Pub 2018.
64. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Close Surgical Margins and Risks of Local Treatment Failure after Wedge Resection of Colorectal Pulmonary Metastases. AATS 98th Annual Meeting, 2018. e-Pub 2018.
65. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. 98th Annual Meeting of the American-Association-for-Thoracic-Surgery, 2018. e-Pub 2018.
66. Nelson DB, Nguyen Q, Erasmus JJ, Tayob N, Mitchell KG, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Local Failure after Stereotactic Body Radiation Therapy (SBRT) or Wedge Resection for Colorectal Pulmonary Metastases. AATS 98th Annual Meeting, 2018. e-Pub 2018.
67. Negrao MV, Reuben A, Chen R, Sepesi B, Karpinets T, Parra E, Federico L, Quek K, Vence L, Weissferdt A, Tran H, Vaporciyan A, Celestiano M, Yee C, Haymaker C, Forget MA, Lizee G, Talukder A, Roszik J, Vasquez M, Prado E, Wu C, Zhang J, Li J, Behrens C, Rodriguez-Canales J, Fujimoto J, Roth J, Meraz I, Roarty E, Landry L, Byers L, William Jr W, Sharma P, Allison J, Fang B, Wagner H, Bogatenkova E, Bernatchez C, Futreal A, Wistuba I, Swisher S, Heymach J, Gibbons D, Zhang J. Prospective immunogenomic profiling of non-small cell lung cancer: genomic and immune profiling updates from Project ICON. WCLC 2018, 2018. e-Pub 2018.
68. Luc JGY, Verrier ED, Allen MS, Aloia L, Baker C, Fann JI, Iannettoni MD, Yang SC, Vaporciyan AA, Antonoff MB. Does cramming work? Impact of National Web-Based Thoracic Surgery Curriculum login frequency on thoracic surgery in-training exam performance. J Thorac Cardiovasc Surg S0022(18):31018, 2018. e-Pub 2018.
69. Haren V, RM, Mehran R, Correa AM, Antonoff MB, Baker CM, Hofstetter WL, Mena GE, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer. STS 2018, 2018. e-Pub 2018.
70. Van Haren RM, Mehran R, Correa AM, Antonoff MB, Baker CM, Hofstetter WL, Mena GE, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. J. Maxwell Chamberlain Memorial Paper for General Thoracic Surgery: Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer. STS 2018 Annual Conference, 2018. e-Pub 2018.
71. Atay SM, Van Haren R, Niu J, Giordano S, Antonoff AM, Hofstetter WL, Mehran R, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Sepesi B. Pathologic Treatment Response is Associated with Increased Overall Survival in Patients Undergoing Neoadjuvant Chemotherapy Followed by Pneumonectomy. STS 2018 Annual Conference, 2018. e-Pub 2018.
72. Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Gl W, Vaporciyan AA, Rice DC. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Meeting of the International-Society-for-Minimally-Invasive-Cardiothoracic-Surgery (ISMICS), 2017. e-Pub 2017.
73. Nelson DB, Godoy M, Shewale J, Correa A, Spicer J, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff M. Clinicoradiographic Predictors of Aggressive Behavior in Resected Malignant Ground Glass Opacity Lesions. WTSA, 2017. e-Pub 2017.
74. Rice D, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy for Lung Cancer?. 2017 ISMICS Annual Scientific Meeting, 2017. e-Pub 2017.
75. Sepesi B, Ye Y, Zhang L, Gu J, Ji L, Antonoff M, Hofstetter WL, Rice D, Mehran R, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic Variants in Cytokine Signaling Pathways Are Associated With Survival in Surgically Resectable Non-Small Cell Lung Cancer. AATS Centennial 2017, 2017. e-Pub 2017.
76. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of Trimodality Therapy and Trends in Therapy for Malignant Pleural Mesothelioma. ESTS 2017, 2017. e-Pub 2017.
77. Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. AATS 2017, 2017. e-Pub 2017.
78. Sepesi B, Cuentes EP, Canales JR, Behrens C, a C, Antonoff M, Gibbons DL, Heymach J, Hofstetter W, Mehran R, Rice DC Roth J, Vaporciyan AA, Walsh G, Weissferdt A, Kahhor N, Moran C, Swisher SG, Wistuba I. Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. Int. J. Radiat. Oncol. Biol. Phys 98(1):223, 2017. e-Pub 2017. PMID: 28586974.
79. Antonoff MB, Shewale J, Nelson DB, Rice D, Sepesi B, Hofstetter W, Mehran RJ, Vaporciyan AA, Walsh G, Swisher S, Roth J. Natural History of Ground Glass Lesions Among Patients with Previous Lung Cancer: Predictors of Progression. AATS Centennial 2017, 2017. e-Pub 2017.
80. Liu X, Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J, Dmitrovsky E. The influence of body mass index on overall survival following surgical resection of non-small cell lung cancer. AACR 2017, 2017. e-Pub 2017.
81. Nelson DB, Correa A, Dhupar R, Goltsov A, Maru D, Sepesi B, Antonoff M, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Davila R, Betancourt S, Skinner H, Blum M, Hofstetter W. Endoscopic Mucosal Resection for Submucosal Esophageal Cancer. AATS 2017, 2017. e-Pub 2017.
82. Antonoff MB, Ragalie W, Sepesi B, Roth J, Walsh GL, Hofstetter W, Swisher S, Rice DC, Vaporciyan A, Mehran R. Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection. 2017 Multidisciplinary Thoracic Cancers Symposium, 2017. e-Pub 2017.
83. Luc JGY, Tc N, Fowler CS, Eisengerg SB, Wolf RK, Strera AL, Vaporciyan AA, Antonoff MB. Novel Debate-Style Cardiothoracic Surgery Journal Club: Results of a Pilot Curriculum. STS 2017, 2017. e-Pub 2017.
84. Vaporciyan AA, Fikfak V, Lineberry MC, Park Y, Tekian AS. Creation of a Coronary Amastomotic Checklist Using a Delphi Technique Reveals Significant Variability Among Experts. STS 53rd Annual Meeting Abstract Book, 2017. e-Pub 2017.
85. Rice DC, Atay S, Mehran RJ, Vaporciyan AA, Sepesi B. Accuracy of Intraoperative Lymph Node Sampling for Predicting Final N Stage in Patients Undergoing Cytoreduction for Malignant Pleural Mesothelioma. 53rd Annual Society of Thoracic Surgeons:360, 2017. e-Pub 2017.
86. Bassuner J, Rice DC, Antonoff MB, Correa A, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Collagen Matrix for Diaphragmatic Reconstruction?. STS 2017, 2017. e-Pub 2017.
87. Bassuner J, Rice DC, Antonoff MB, Correa A, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrauoroethylene or Collagen Matrix for Diaphragmatic Reconstruction?. STS 2017 (#P91), 2017. e-Pub 2017.
88. Roszik J, Gibbons DL, Heymach J, Vaporciyan AA, Swisher S, Sepesi B. Lung Cancer PD-L1 mRNA Expression Profile and Clinical Outcomes - An Analysis From The Cancer Genome Atlas and Cancer Cell Line Encyclopedia. IASLC 2016, 2016. e-Pub 2016.
89. Sepesi B, Weissferdt A, Vaporciyan AA, Futreal A, Karpinets T, Yee C, Haymaker C, Federico L, Forget MA, Lizee G, Talukder A, Roszik J, Tran H, Vasquez M, Prado E, Gehrens C, Parra E, Rodriguez-Canales J, Fujimoto J, Vence L, Roth J, Meraz I, Roarty E, Landry L, Byers L, Swisher SG, William Jr W, Allison S, Fang B, Zhang J, Wagner H, Bogatenkova E, Wistuba II, Heymach JV, Bernatches C, Gibbons D. Prospective Immunogenomic Profiling of Non-small cell lung cancer - the ICON Project. IASLC WCLC 2016, 2016. e-Pub 2016.
90. Haymaker C, Federico L, Forget MA, Vence LM, Sharma P, Allison JP, Fang B, Zhang J, Wagner H, Bogatenkova E, Wistuba I, Sepesi B, Heymach J, Gibbons D, Bernatchez C, Weissferdt A, Vaporciyan AA, Futreal A, Karpinets T, Yee C, Lizee G, Talukder A, Roszik J, Tran H, Vasquez M, Prado E, Behrens C, Parra E, Rodriguez-Canales J, Fujimoto J, Roth J, Meraz I, Roarty E, Landry L, Byers L, Kalhor N, Swisher SG, William Jr W. Phenotypic and functional profiling of tumor-infiltrating lymphocytes (TIL) in early stage non-small cell lung cancer (NSCLC). IASLC WCLC, 2016. e-Pub 2016.
91. Atay SM, Niu J, Giordano SH, Antonoff M, Heymach J, Hofstetter WL, Mehran R, Rice D, Roth JA, Vaporciyan A, Walsh G, William W, Swisher S, Sepesi B. Perioperative Outcomes and Downstaging Following Neoadjuvant Therapy For Lung Cancer - Analysis of the National Cancer Database. IASLC 2016, 2016. e-Pub 2016.
92. Atay S, Correa A, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Pulmonary Lobectomy on Clopidogrel. STSA 63rd annual Meeting, 2016. e-Pub 2016.
93. Sceusi E, Atay S, Correa A, Swisher S, Vaporciyan A, Roth J, Walsh G, Hofstetter W, Mehran R, Rice D, Sepesi B, Antonoff M. Outcomes for Patients with Surgically Resected Thymic Neuroendocrine Tumors. NANETS Symposium: Exploring Novel Mechanisms and Therapies for Neuroendocrine Cancers, 2016. e-Pub 2016.
94. Sepesi B, Cuentas ED, Canales JR, Behrens C, Correa A, Antonoff, M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. The Expression of Programmed Death 1 Ligand (PD-L1) in the Tumor and Tumor Infiltrating Macrophages Predicts Overall and Disease Free Survival in Surgically Resected Pathologic Stage I Non-Small Cell Lung Cancer. Western Thoracic Surgical Association, 2016. e-Pub 2016.
95. Lopez C, Correa A, Vaporciyan A, Austin M, Rice D, Hayes-Jordan A. Outcomes of Chest Wall Resections in Pediatric Sarcoma Patients. American Pediatric Surgical Association, 2016. e-Pub 2016.
96. Antonoff MB, Correa A, Sepesi B, Nguyen Q, Walsh G, Swisher S, Vaporciyan A, Mehran R, Hofstetter W, Rice D. Salvage Pulmonary Resection Following SBRT: A Feasible and Safe Option for Local Failure. American Association for Thoracic Surgery, 2016. e-Pub 2016.
97. Sceusi E, Leiva-Juarez M, Mehran R, Neda K, Shaw K, Futreal A, Correa A, Moran C, Wistuba I, Junya F, Rao X, Swisher S, Vaporciyan A, Wang J, Antonoff M, Hofstetter W, Rice D, Sepesi B, Walsh G, Roth J. Well Differentiated Neuroendocrine Carcinoma (Typical Carcinoid) with Mediastinal Lymph Node Metastases: Surgical Outcomes and Whole Exome Sequencing (WES). American Association of Thoracic Surgery, 2016. e-Pub 2016.
98. Antonoff M, Verrier E, Allen M, Aloia L, Baker C, Fann J, Lannettoni M, Yang S, Vaporciyan A. Impact of Moodle-Based Online Curriculum on Thoracic Surgery In-Training Exam Scores. 2016 STS 52nd Annual Meeting (#332), 2016. e-Pub 2016.
99. Sanchez N, Shewale JB, Baker C, Wilks SA, Correa AM, Sepesi B, Mehran R, Rice DC, Roth JA, Walsh GL, Swisher SG, Vaporciyan A, Hofstetter W. Implications of Early Foley Removal in Thoracic Surgical Oncology Patients Utilizing Epidural Analgesia. 2015 STSA, 2015. e-Pub 2015.
100. Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter W, Rice DC, Vaporciyan A, Mehran R, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Outcomes Following Chest Wall Resection. STSA 2015, 2015. e-Pub 2015.
101. Spicer JD, Shewale J, Correa AM, Heymach JV, Antonoff MB, Hofstetter W, Mehran R, Roth J, Rice D, Sepesi B, Vaporciyan AA, William W, Walsh G, Swisher S. Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience. IASLC 2015, 2015. e-Pub 2015.
102. Spicer J, Shewale J, Sepesi B, Antonoff M, Correa A, Hofstetter W, Rice D, Vaporciyan A, Mehran R, Walsh G, Roth J, Swisher S. The Role of Pneumonectomy After Neoadjuvant Chemotherapy for N2 Non-Small Cell Lung Cancer. Canadian Surgery Forum 2015, 2015. e-Pub 2015.
103. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, WlL H, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Indications For Counseling And Intervention After Pulmonary Resection: Results Of Post-discharge Nursing Telephone Assessments. Western Thoracic Surgical Association Annual Meeting, 2015. e-Pub 2015.
104. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, WlL H, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Western Thoracic Surgical Association Annual Meeting 2015, 2015. e-Pub 2015.
105. Antonoff MB, Verrier ED, Yang SC, Lin J, DeArmond DT, Allen MS, Jr VT, Sengewald D, Vaporciyan AA. Online learning in thoracic surgical training: promising results of multi-institutional pilot study. University of Texas MD Anderson Cancer Center 2015 Education Week Educational Scholarship Poster Session, 2015. e-Pub 2015.
106. Shah AY, Campbell MT, Nautiyal KD, Hashemi N, Matin SF, Vaporciyan AA, Rhines LD, Moon B, Lewis VO, Lin PP, Prabhu SS, Rao G, Corn PG, Pagliaro LC, Mehran RJ, Wood CG, Jonasch E, Tannir NM. Long-term survivorship in patients with metastatic renal cell cancer (mRCC) managed with metastasectomy: A retrospective study from the MD Anderson Cancer Center (MDACC). 2015 Genitourinary Cancers Symposium, 2015. e-Pub 2015.
107. Sepesi B, Schmidt HE, Lada M, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Surgical Therapy Is An Important Multimodality Component in Patient with Distal Esophageal Adenocarcinoma Independent of Regional Lymph Node Location. STSA 2014, 2014. e-Pub 2014.
108. Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Walsh GL, Swisher SG, Hofstetter WL. Trends and Improving Outcomes of 882 Surgical Patients With Gastro-Esophageal Junction Adenocarcinoma – A Single Institution Experience. The International Society for Diseases of the Esophagus, 2014. e-Pub 2014.
109. Antonoff MB, Verrier ED, Yang S, Lin J, DeArmond DT, Allen MS, Varghese TK, Sengewald D, Vaporciyan AA. Novel Use of Online Learning to Supplement Thoracic Surgical Training: Promising Results of a Moodle-based Multi-institutional Pilot Study. University of Texas MD Anderson Cancer Center Educational Scholarship Poster Session, 2014. e-Pub 2014.
110. Sepesi B, Hofstetter W, Rice DC, Mehran RJ, Vaporciyan AA, Walsh G, Roth JA, Swisher SG. Experience with Primary and Metastatic Adenoid Cystic Carcinoma. 2014 Society of Surgical Oncology Annual Cancer Symposium, 2014. e-Pub 2014.
111. Francis AM, Correa AM, Betancourt-Cuellar SL, Kim JY, Sepesi B, Ajani JA, Komaki R, Erasmus J, Maru D, Munden RF, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG. Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation. Academic Surgical Congress 2014, 2014. e-Pub 2014.
112. Antonoff MB, Verrier ED, Yang SC, Lin J, DeArmond DT, Allen MS, Varghese TK, Sengewald D, Vaporciyan, AA. Novel Use of Online Learning to Supplement Thoracic Surgical Training: Promising Results of a Moodle-Based-institutional Pilot Study. Society of Thoracic Surgeons Annual Meeting, 2014. e-Pub 2014.
113. Rodriguez LE, Ramlawi B, Blackmon SH, Vaporciyan AA, Bunge R, Shapira OM, Reardon MJ. Cardiac Autotransplantation for Malignant and Complex Left-Sided Cardiac Tumors: A 15-Year Experience. Society of Thoracic Surgeons Annual Meeting, 2014. e-Pub 2014.
114. Kim MP, Correa AM, Blackmon SH, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Preoperative Flourodeoxyglucose-Positron Emission Tomography Scan with Positive N1 Disease Does Not Predict Worse Survival in Pathologic Stage II Patients. IASLC 2013, 2013. e-Pub 2013.
115. Kim E, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. Telomere length and recurrence risk after curative resection in women with adenocarcinoma of the lung: A prospective cohort study. Proc Am Soc Clin Oncol, 2013. e-Pub 2013.
116. Stephens A, Rice D, Swisher S, Vaporciyan A, Hofstetter W, Walsh G, Mehran R, Roth. VATS lobectomy is Associated with Improved Short-Term and Long-Term Outcomes Compared to Open Lobectomy for C-Stage I NSCLC: A Propensity-Matched Analysis of 963 Cases. 21st European Conference on General Thoracic Surgery, 2013. e-Pub 2013.
117. Chowdhuri SR, Zaidi TM, Khanna A, Jiang F, Spitz MR, Vaporciyan AA, Roth JA, Ensor J, Katz RL. Deletion of 3p22.1 by FISH in non-small cell lung cancer (NSCLC) is significantly correlated with loss of ß-catenin membrane expression and dysregulated cell adhesion. Proc Am Assoc Cancer Res, 2013. e-Pub 2013.
118. Francis AM, Sepesi B, Correa A, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh J, Swisher SG, Hofstetter WL. Long-Term Survival and Recurrence Rates Following Trimodality Therapy of Esophageal Adenocarcinoma – The Influence of Histologic Tumor Viability. ASA 2013 Annual Meeting, 2013. e-Pub 2013.
119. Subbiah IM, Blackmon SH, Correa AM, Kee BK, Vaporciyan AA, Swisher SG, Eng C. Preoperative chemotherapy prior to pulmonary metastatecomy in patients with prior surgically resected primary colorectal carcinoma. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
120. Yang SC, Higgins RS, Vaporciyan AA, Merrill WH. The Society of Thoracic Surgeons "Looking to the Future" Scholarship Program: Outcomes of Our Investment in 184 Recipients. Society of Thoracic Surgeons Annual Meeting, 2013. e-Pub 2013.
121. David EA, Wai C, Correa AM, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Thall PF, Mehran RJ. Visceral Pleural Invasion is not Predictive of Survival in NSCLC Patients with Small Tumors in a North American Patient Population. Society of Thoracic Surgeons Annual Meeting, 2013. e-Pub 2013.
122. Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele BN, Erasmus JJ, Hofstetter W, Kim ES, Komaki R, Mehran RJ, Moran CA, Papadimitrakopoulou V, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, William WN, Wistuba I, Swisher SG. The Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC Seventh) Following Neoadjuvant Chemotherapy. Society of Thoracic Surgeons, 2013. e-Pub 2013.
123. Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter W. Diaghragmatic Hernia After Esophagectomy in 440 Patients with Long-Term Follow-up. Southern Thoracic Surgical Association Annual Meeting, 2012. e-Pub 2012.
124. Cheedella NKS, Suzuki A, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Maru DM, Vaporciyan AA, Taketa T, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Walsh GL, Swisher S, Ajani JA. Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT). 2012 ASCO Annual Meeting, 2012. e-Pub 2012.
125. Lin SH, Amini A, Lou F, Correa A, Roth JA, Swisher SG, Huang J, Rimner A, Vaporciyan AA. Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery. Proc Am Soc Clin Oncol, 2012. e-Pub 2012.
126. Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. Genetic variations in epidermal growth factor receptor pathway predict recurrence and response to chemotherapy in early stage non-small cell lung cancer. Proc Am Assoc Cancer Res, 2012. e-Pub 2012.
127. Sepesi B, Swisher SG, Walsh GL, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Hofstetter WL. Omental Reinforcement of the Thoracic Esophagogastric Anastomosis - An Analysis of Leak and Reintervention Rates in Planned and Salvage Esophagectomy Patients. American Association for Thoracic Surgery Annual Meeting, 2012. e-Pub 2012.
128. Lin SH, Myles BH, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher S, Lee JH, Bhutani MS, Maru D, Ajani JA, Cox JD, Komaki R, Liao ZX. Propensity score–based comparison of outcomes with 3D conformal radiotherapy (3D-CRT) versus intensity-modulated radiation therapy (IMRT) in treatment of esophageal cancer. 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
129. Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, Swisher S, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH. Effect of technologic advancements in radiotherapy on postoperative pulmonary complications after neoadjuvant chemoradiation in esophageal cancer. 2012 Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
130. Blackmon SH, Stephens E, Correa AM, Hofstetter W, Kim MP, Mehran R, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrence in the Lung and Survival in Pulmonary Metastasectomy for Colorectal Carcinoma Patients. STS 48th Annual Meeting, 2012. e-Pub 2012.
131. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Yu P, Hofstetter WL. Super-Charged Pedicled Jejunal Interposition for Esophageal Replacement: A 10-Year Experience. Society of Thoracic Surgeons Annual Meeting, 2012. e-Pub 2012.
132. Marks JL, Hofstetter WL, Correa AM, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma. Society of Thoracic Surgeons Annual Meeting, 2012. e-Pub 2012.
133. Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Genetic Variations in the VEGF Pathway are Associated with Postoperative Pulmonary Complications After Lung Resection. Society of Thoracic Surgeons Annual Meeting, 2012. e-Pub 2012.
134. Amini A, Lin SH, Correa AM, Swisher SG, Roth JA, Vaporciyan AA. Locoregional Recurrence Rate in Resected Stage III-N2 Non-Small Cell Lung Cancers (NSCLC) with Nodal Downstaging following Induction Chemotherapy. Int J Radiat Oncol Biol Phys 81(2):S134, 2011. e-Pub 2011.
135. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutani MS, Lin SH, Welsh J, Maru D, Swisher S, Ajani JA. The association between body mass index and baseline clinical stage of esophageal carcinoma. 2011 ASCO Annual Meeting, 2011. e-Pub 2011.
136. Harvin JA, Lahat G, Correa AM, Lee JL, Maru D, Ajani JA, Marom EM, Welsh J, Walsh GL, Roth JA, Mehran RJ, Vaporciyan AA, Rice DC, Swisher SG, Hofstetter WL. Neoadjuvant Chemoradiation Followed by Surgery for Esophageal Adenocarcinoma: Significance of Microscopically Positive Circumferential Margins. American Association for Thoracic Surgery Annual Meeting, 2011. e-Pub 2011.
137. Kim ES, Vaporciyan AA, Xing J, Huang M, Gu J, Roth J, Lippman SM, Wu X. Use of telomere length and genetic variations in maintenance genes to predict risk of recurrence and survival in patients with early-stage non-small cell lung cancer. Proc Am Assoc Cancer Res, 2011. e-Pub 2011.
138. Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the p38 signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Proc Am Assoc Cancer Res, 2011. e-Pub 2011.
139. Gold KA, William WN, Lee JJ, Vaporciyan AA, Herbst RS, Tse W, Stewart D, Hofstetter WL, Wistuba II, Swisher SG, Lippman SM, Kim ES. Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with resectable non-small cell lung cancer (NSCLC). Targeted Therapies for Lung Cancer Annual Meeting, 2011. e-Pub 2011.
140. Kim JY, Correa AM, Swisher SG, Rice DC, Walsh GL, Vaporciyan AA, Mehran RJ, Roth JA, Bhutani M, Maru D, Welsh J, Ajani J, Rohren E, Hofstetter WL. Does the Timing of Esophagectomy After Neoadjuvant Chemoradiation Affect Outcome?. Society of Thoracic Surgeons Annual Meeting, 2011. e-Pub 2011.
141. Brouquet A, Vauthey JN, Contreras C, Walsh G, Vaporicyan AA, Swisher SG, Curley S, Mehran RJ, Abdalla E. Improved Survival After Resection of Liver and Lung Colorectal Metastases Compared to Resection of Liver-Only Metastases: A Study of 112 Patients with Limited Lung Metastatic Disease. Western Surgical Association Annual Meeting, 2010. e-Pub 2010.
142. Blackmon SH, Stephens EH, Correa AM, Roth JA, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression following chemotherapy is a novel predictor of poor outcome following pulmonary metastasectomy in sarcoma patients. J Am Coll Surg Supp 211(3):S35, 2010. e-Pub 2010.
143. Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Spitz MR, Wu X. Association of Genetic variations in DNA-methyltransferases, histone-methyltransferases and methylated DNA binding proteins are associated with recurrence and survival in early stage non-small-cell-lung cancer treated with surgery alone or surgery and chemotherapy. 2010 ASCO Annual Meeting, 2010. e-Pub 2010.
144. Kim ES, Vaporciyan AA, Xing J, Huang M, Spitz MR, Lippman SM, Gu J, Roth JA, Wu X. Use of telomere length in peripheral leukocytes to predict risk of recurrence in patients with early-stage non-small cell lung cancer after curative resection. 2010 ASCO Annual Meeting, 2010. e-Pub 2010.
145. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Ajani JA, Erasmus J, Komaki R, Lee JHL, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Peters JH, Watson TJ, Swisher SG. A Clinical Nomogram Predicting Pathologic Lymph-Node Involvement in Esophageal Cancer Patients. 130th Annual American Surgical Association:77, 2010. e-Pub 2010.
146. Kim MP, Hofstetter WL, Correa A, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Ajani JA, Maru DM, Chang JY, Marom EM, Macpinlac HA, Lee JH, Swisher SG. Pathologic T0N1 after neoadjuvant therapy and surgery for esophageal cancer: an orphan status. 46th Annual Meeting Program, The Society of Thoracic Surgeons, 2010. e-Pub 2010.
147. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The Influence of Pretreatment Body Mass Index on Long-Term Prognosis of Patients with Esophageal Carcinoma After Surgery. 2010 ASCO Annual Meeting, 2010. e-Pub 2010.
148. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The Influence of Pretreatment Body Mass Index on Long-Term Prognosis of Patients with Esophageal Carcinoma After Surgery. Gastrointest Cancer Res, 2010. e-Pub 2010.
149. Kim MP, Correa A, Moran C, Erasmus J, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA. Resection of Lung Cancer in Lymphoma Survivors. 46th Annual Meeting Program, The Society of Thoracic Surgeons, 2010. e-Pub 2010.
150. Swisher SG, Hofstetter WL Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru DM, Mehran RJ, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome With Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. Southern Thoracic Surgical Association 2009, 2009. e-Pub 2009.
151. Gaur P, Hofstetter WL, Bekele NB, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Staging of Gastroesophageal Adenocarcinomas: A Comparison Between Esophageal Staging, Gastric Staging, and a Novel Worldwide Esophageal Cancer Collaboration Staging System. STSA 65th Annual Meeting 2009, 2009. e-Pub 2009.
152. Correa AM, Hayashi Y, Hofstetter WL, Komaki R, Vaporciyan AA, Rice DC, Walsh GL, Lee JH, Bhutani MS, Ross WA, Liao Z, Swisher SG, Ajani JA. In Patients with Clinical T2N0M0 Esophageal Cancer, Surgery First or Preoperative Chemoradiotherapy?. 2009 Gastrointestinal Oncology Conference, 2009. e-Pub 2009.
153. Smith KD, Rice D, Blazer D, Wang X, Vaporicyan AA, Hunt KK, Swisher SG, Cormier J, Pisters PW, Pollock RE, Feig BW. Near-margin adventitial (NMA) vascular dissection is equivalent to en bloc vascular resection in soft tissue sarcomas (STS). Society of Surgical Oncology, 2009. e-Pub 2009.
154. Gaur R, Correa AM, Huang JL, Hofstetter W, Maru D, Mehran R, Roth JA, Vaporciyan A, Walsh GL, Swisher SG. Correlation of endoscopic tumor length with lymph node involvement and poor long-term survival in esophageal cancer patients. Gastrointestinal Cancers Symposium, 2009. e-Pub 2009.
155. Rice DC, Lee JH, Jimenez C, Eapen G, Stewart J, Hofstetter WL, Mehran R, Vaporciyan AA, Walsh GL, Swisher SG. Mediastinal Staging for Mesothelioma: Endoscopic Ultrasound or Mediastinoscopy?. Society of Thoracic Surgeons, 2009. e-Pub 2009.
156. Blackmon S, Shah N, Correa AM, Benjamin R, Hofstetter W, Lev D, Pollock R, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran R. Complete Resection of Extra-Pulmonary Sarcomatous Metastases in Addition to Pulmonary Metastasectomy is Associated with Long-Term Survival. Society of Thoracic Surgeons Annual Meeting, 2009. e-Pub 2009.
157. Norman PH, Vaporciyan AA, Rice DC, Correa AM. Rofecoxib provides significant improvement in survival following lung resection for cancer. American Society of Anesthesiologists, 2008. e-Pub 2008.
158. Mehran R, Shah N, Correa A, Vaporciyan A, Rice D, Hofstetter W, Walsh G, Benjamin R, Swisher S, Pollock R, Roth J. Pulmonary Metastatectomy In Sarcoma Patients With Extra-Thoracic Metastases. 18th World Congress of the World Society of Cardio-Thoracic Surgeons, 2008. e-Pub 2008.
159. Cen P, Correa A, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan AA, Ajani JA. Adenocarcinoma of the Lower Esophagus with Barrett's or without Barrett's: Differences in Patients Survival After Preoperative Chemoradiation. ASCO 2008 Meeting, 2008. e-Pub 2008.
160. Vaporciyan A, Wang XS, Bashkar S, Correa A, Shi Q, Gning I, Hofstetter W, Rice D, Mehran R, Swisher S, Cleeland C. A Novel system for Measuring Longitudinal Postoperative Symptom Burden: proof of Concept Comparing VATS versus Open Lobectomy. ISMICS 2008 Annual Sceintific Meeting 3(2):63, 2008. e-Pub 2008.
161. Bolton W, Rice D, Goodyear A, Correa A, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Long-Term Survival with Surgical Management For Superior Sulcus Tumors with Vertebral Resection. Proc Am Assoc Thorac Surg, 2008. e-Pub 2008.
162. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele N, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the Revised Lung Cancer Staging System (IASLC Staging Project) to a Cancer Center Population, 2008. e-Pub 2008.
163. Bolton WD, Hofstetter W, Francis A, Correa AM, Ajani JA, Bhutani B, Erasmus J, Komaki R, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of Tumor Length and Submucosal Involvement on the Long-Term Survival of pT1 Early Stage Esophageal Adenocarcinoma. Proc Am Assoc Thorac Surg, 2008. e-Pub 2008.
164. Yendamuri S, Vaporciyan AA, Zaidi T, Fernandez R, Rice DC, Walsh GL, Swisher SG, Spitz M, Roth JA, Katz RL. Deletion of chromosome 10q detected by luorescent in situ hybridization (FISH) is a potential new tool for early detection of non small cell lung cancer (NSCLC). 12th World Conference on Lung Cancer 2(8):S357-S357, 2007. e-Pub 2007.
165. Rice D, Correa A, Hofstetter W, Mehran R, Swisher S, Walsh G, Vaporciyan A, Roth J. Recent Survival Trends for Clinically Staged Stage I Lung Cancer. Society of Thoracic Surgeons 43rd Annual Meeting, 2007. e-Pub 2007.
166. Blackmon SH, Rice DC, Correa AM, Hofstetter W, Swisher SG, Mehran R, Vaporciyan AA, Walsh GL, Roth JA. Does A Gastrostomy Tube Versus Jejunostomy Tube Prior To Esophagectomy For Primary Esophageal Cancer Patients Have Additional Risk?. Society of Thoracic Surgeons 43rd Annual Meeting, 2007. e-Pub 2007.
167. Javeri HA, Arora R, Correa AM, Dixon DR, Komaki R, Hofstetter WL, Rice DC, Walsh GL, Vaporciyan AA, Swisher AG, Lee JH, Bhutani M, Ross WA, Liao Z, Maru DM, Dekovich AA, Ajani JA. Comparison of the outcomes of patients with localized esophageal carcinoma receiving bimodal therapy versus trimodal therapy. International Society of Gastrointestinal Oncology (Poster presentation), 2007. e-Pub 2007.
168. Yendamuri S, Walsh G, Vaporciyan A, Hofstetter W, Rice DC, Mehran RJ, Roth JA. Comparison of limited surgery and 3D conformal radiation in high risk patients with stage IA non small cell lung cancer: A propensity score matched analysis. J Thorac Oncol 2(8):S388, 2007. e-Pub 2007.
169. Yendamuri S, Vaporciyan AA, Zaidi T, Fernandez R, Rice DC, Spitz M, Swisher S, Walsh GL, Roth JA, Katz RL. 3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 25:18S, 2007. e-Pub 2007.
170. Bakaeen F, Chu D, Correa AM, Rice D, McAllister R, Vaporciyan AA, Walsh G, Putnam JB, Swisher SG, Roth JA, Huh J, Smythe, WR. The Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis And Blood Product Utilization. Association of VA Surgeons Meeting, 2006. e-Pub 2006.
171. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased Risk of Aspiration and Pulmonary Complications after Lung Resection in Head and Neck Cancer Patients. STS 42nd Annual Meeting:214, 2006. e-Pub 2006.
172. Hofstetter W, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu TT, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Proposed Modifications of Nodal Status in AJCC Esophageal Cancer Staging System. 53rd Annual Meeting Southern Thoracic Surgeon’s Association, 2006. e-Pub 2006.
173. Brown K, Bisanz A, Walsh G, Vaporciyan AA, Hofstetter W. A Proactive approach to preventing constipation in postoperative oncology pulmonary resection patients. Oncology Nursing Forum 33:414, 2006. e-Pub 2006.
174. Rice DC, Liao Z, Vaporciyan AA, Smythe WR, Forster K, Liu H, Guerrero T, komaki R, Cox J, Stevens C. Quantity of radiation received by the contralateral lung predicts fatal pulmonary events after intensity modulated radiation therapy following extrapleural pneumonectomy for mesothelioma. Chest 130:90S-91S, 2006. e-Pub 2006.
175. Rice DC, Liao Z, Vaporciyan AA, Smythe R, Forster K, Liu H, Guerrero T, Komaki R, Cox J, Stevens C. V20 predicts fatal pulmonary toxicity after extrapleural pneumonectomy and intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 66:S63, 2006. e-Pub 2006.
176. Liao Z, Liu HH, Tucker SL, Wei X, Wang S, Vaporciyan AA, Rice D, Mohan R, Cox JD, Komaki R. The volume of lung receiving low radiation dose is associated with treatment related lung toxicity when irradiating tumors in the thorax. Int J Radiat Oncol Biol Phys 66:S472, 2006. e-Pub 2006.
177. Blackmon SH, Martin LW, Correa AM, Wynn B, Hofstetter W, Mehran R, Rice D, Swisher S, Walsh GL, Roth JA, Vaporciyan AA. Propensity matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Southern Thoracic Surgical Association 53rd Annual Meeting, 2006. e-Pub 2006.
178. Stevens C, Rice D, Forster K, Liao Z, Guerrero T, Correa A, Vaporciyan AA, Smythe WR. Extrapleural pneumonectomy followed by IMRT: Results of a phase I/II Study. J Clin Oncol 23:664S, 2006. e-Pub 2006.
179. Rice DC, Stevens C, Forster K, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter W, Mehran RJ, Roth JA, Liao Z, Smythe WR. Survival and recurrence patterns following extrapleural pneumonectomy and intensity modulated radiation therapy for malignant pleural mesothelioma. Southern Thoracic Surgical Association 53rd Annual Meeting, 2006. e-Pub 2006.
180. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. STS 2005, 2005. e-Pub 2005.
181. Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe RW, Putnam JB, Hofstetter WL, Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA. Outcomes for resected stage IIIA Non-Small Cell Lung Cancer over 15 years at a single institution. Proc Am Assoc Thorac Surg:72, 2005. e-Pub 2005.
182. Ascioti AA, Hofstetter, WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Jr PJ, Smythe WR, Walsh GL. Long segment supercharged predicled jejunal flap for total esophageal reconstruction. Proc Am Assoc Thorac Surg:98, 2005. e-Pub 2005.
183. Malaisrie SC, Correa AM, Ajani JA, Komaki RR, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus. Proc Am Assoc Thorac Surg:102, 2005. e-Pub 2005.
184. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant mesothelioma. STS 80(6):1988-1993, 2005. e-Pub 2005.
185. Katz RL, Fernandez RL, Zaidi TM, Caraway NP, Tedja M, Vaporciyan AA, Bekele N, Spitz MR. Telomere length in stage I non-small cell carcinoma of lung (NSCL) is associated with smoking history. Laboratory Investigation 18:313A, 2005. e-Pub 2005.
186. Katz RL, Fernandez RL, Zaidi TM, Caraway NP, Tedja M, Vaporciyan AA, Bekele N, Spitz MR. Telomere length in stage I non-small cell carcinoma of lung (NSCL) is associated with smoking history. Modern Pathology 18:313A, 2005. e-Pub 2005.
187. Jaroszewski ED, Rice DC, Vaporciyan AA, Walsh LG, Seabolt BP, Bakaeen GF, Reardon JM. Multi-Modality Treatment of Primary Cardiac Sarcomas. European Association for Cardiovascular Surgery 54th International Congress, 2005. e-Pub 2005.
188. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG. The Addition of Induction Chemotherapy to Preoperative Concurrent Chemoradiotherapy Improves Tumor Response in Patients with Esophageal Adenocarcinoma. Western Thoracic Surgical Association, 2005. e-Pub 2005.
189. Martin LW, Swisher SG, Hofstetter W, Correa AM, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. American Surgical Assoc 64, 2005. e-Pub 2005.
190. Wang S, Liao Z, Vaporciyan AA, Tucker S, Liu H, Wei X, Mohan R, Swisher S, Ajani J, Cox J, Komaki R. Dose-volume analyses of postoperative lung complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 53:S163, 2005. e-Pub 2005.
191. Jeter MD, Zhu G, Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Guerrero T, Stevens C, Vaporciyan AA, Komaki R. Induction chemotherapy improves long-term survival of patients with respectable esophageal cancer receiving chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 63:S275, 2005. e-Pub 2005.
192. Rohatgi P, Swisher S, Correa A, Wu TT, Liao X, Komaki R, Walsh G, Vaporciyan A, Rice DC, Roth JA, Ajani JA. Degree of pathologic response after preoperative chemoradiotherapy correlates with failure patterns and outcome of patients with carcinoma of the esophagus. Proc Am Assoc Cancer Res 46, 2005. e-Pub 2005.
193. Swisher SG, Maish M, Erasmus J, Correa AM, Rice D, Putnam JB, Smythe WR, Walsh G, Vaporciyan A, Roth J. Utility of PET, CT, and EUS to Identify Pathologic Responders In Esophageal Cancer. Proc Soc Thorac Surg:170-171, 2004. e-Pub 2004.
194. Komaki R, Putnam JB, Roth JR, Allen P, Swisher S, Walsh G, Kies M, Fossella FV, Hong WK, Herbst R, Oh YW, Liao Z, Vaporciyan AA, Rice D, Smythe WR, Munden R, Cox JD. Does Surgery and pre-operative treatments improve the outcome of patients with locally advanced superior sulcus tumor (SST)?. ARS, 2004. e-Pub 2004.
195. Swisher SG, Erasmus J, Maish M, Correa AM, Ajani J, Cox J, Komaki R, Lee HK, Macapinlac H, Putnam JB, Rice D, Smythe WR, Vaporciyan A, Walsh G, Hong D, Wu TT, Pollock R, Roth J. PET predicts pathologic response and long-term survival following preoperative chemoradiation in esophageal cancer. Proc Am Soc Clin Oncol - GI Symposium, 2004. e-Pub 2004.
196. Swisher SG, Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA. Impact of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation (CRT). Proc South Surg Assoc:55, 2004. e-Pub 2004.
197. Vaporciyan AA, Lee H, Cox J, Swisher SG, Komaki R, Smythe WR, Walsh GL, Rice DC, Roth JA, Putnam JB, Jr. The impact of chemoradiotherapy on pulmonary morbidity after esophagectomy. Proc Am Assoc Thorac Surg, 2004. e-Pub 2004.
198. Jaffe N, Pearson M, Putnam J, Smythe W, Vaporciyan AA, Bellow M, Blakely M. Pediatric Osteosarcoma: Pneumonectomy for Pulmonary metastases: Is it Justified?. ASCO, 2004. e-Pub 2004.
199. Agarwal B, Swisher S, Kelly K, Ajani J, Komaki R, Molke K, Lehman J, Walsh G, Correa A, Ho LN, Liao ZX, Lynch P, Rice D, Smythe R, Steven C, Vaporciyan AA, Yao J, Roth J. Pre-operative chemoradiation downstages esophageal adenocarcinoma and abolishes differences in post-operative survival between T3N0 and T3N1 esophageal cancers. Gastroenterology 124:A652, 2003. e-Pub 2003.
200. Rice DC, Swisher SG, Correa AM, Ajani JA, Putnam JB, Smythe WR, Walsh GL, Vaporciyan AA, Roth JA. Induction chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thor Surg:266-267, 2003. e-Pub 2003.
201. Vaporciyan AA, Correa A, Rice D, Roth J, Smythe W, Swisher SWalsh G, Jr PJ. Identification of Risk factors associated with atrial fibrillation after thoracic surgery: prospective analysis of 2,335 patients. Proc. Am. Assoc. Thorac. Surg:83, 2003. e-Pub 2003.
202. Jr PJ, Correa A, Swisher SG, Smythe WR, Rice DC, Roth JA, Vaporciyan AA, Walsh GL. A model for prospective quality improvement in thoracic surgical oncology, 2003. e-Pub 2003.
203. Swisher SG, Ajani JA, Komaki RR, Nesbitt JC, Cox J, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Final Results of Phase II Trial Evaluating Chemotherapy, Concurrent Chemoradiation and Surgery in Locoregionally Advanced Esophageal Cancer. American College of Surgeons, South Texas Chapter, Annual Meeting, 2003. e-Pub 2003.
204. Lee HK, Vaporciyan AA, Cox JA, Jr PJ, Ajani AA, Liao Z, Swisher SG, Roth JA, Smythe RW, Walsh GL, Mohan R, Komaki R. Postoperative pulmonary complications following preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram. Proc. Am. Soc. Ther. Radiol. Oncol 54:132-133, 2002. e-Pub 2002.
205. Agarwal B, Swisher S, Kelly K, Lynch P, Ajani J, Komaki RR, Putanm JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Kelly J, Liao ZX, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Role of EUS lymph node assessment after preoperative chmoXRT in esophageal cancer patients. Gastrointestinal Endoscopy 55:AB229, 2002. e-Pub 2002.
206. Agarwal B, Swisher S, Kelly K, Ajani J, Komaki RU, Putnam JB, Molke KL, Lehman J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Lynch P, Rice DC, Smythe WR, Steven CW, Vaporciyan AA, Yao J, Roth JA. Determinants of response to chemoradiation in patients with esophageal cancer. Proc. Am. Gastroenterol. Assoc 122:A351, 2002. e-Pub 2002.
207. Rice DC, Kim HW, Putnam JB, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Lee JJ, Sabichi A, Lippman SM, Roth JA. The risk of second primary lung cancer after resection of stage I non-small-cell lung cancer. Proc. Soc. Thor. Surg:108, 2002. e-Pub 2002.
208. Jr PJ, Robersonjan SL, Lewin S, Correa AM, Swisher SG, Walsh GL, Rice DC, Vaporciyan AA, Roth JA, Smythe WR. Risk analysis for pneumonia following esophagectomy. Proc. Soc. Thor. Surg:258, 2002. e-Pub 2002.
209. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Bu-Hamda I, Moke KL, Walsh GL, Correa AM, Ho L, Liao ZX, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Persistent malignant lyphadenopathy after preoperative chemoradiation identifies patients with poor postoperative survival. Gastrointestinal Endoscopy 56:S110, 2002. e-Pub 2002.
210. Hofstetter W, Swisher SG, Correa AM, Jr PJ, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Evolving treatment outcomes of resected esophageal cancer over three decades for 951 patients at a single institution. Proc. Am. Surg. Assoc, 2002. e-Pub 2002.
211. Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Jr. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Proc South Thorac Surg, 2002. e-Pub 2002.
212. Ahdarinia A, Yang DJ, Sharma C, Vaporciyan A, Yu DF, Kim EE, Podoloff DA. Human Lung Tumor Cells Detection of Apoptosis Using Radiolabeled Annexin V. J. Nucl. Med 41, 2001. e-Pub 2001.
213. Vaporciyan AA, Rice DC, Correa AM, Walsh GL, Swisher SG, Smythe WR, Putnam JB, Roth JA. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass (CPB). Proc Eur Assoc Cardiothorac Surg, 2001. e-Pub 2001.
214. Sharma C, Roth J, Vaporciyan A. Perfluorocarbon improves adenoviral-mediated transfection of lung cancer cell lines via cell mediated effects. Clin Cancer Res 7:3781s-3782s, 2001. e-Pub 2001.
215. Swisher SG, Roth JA, Komaki R, Hicks M, Ro J, Hong WK, Ahrar K, Correa A, Dolormente M, Dreiling L, Fang B, Fossela F, Francisco R, Glisson B, Herbst R, Huaringa A, Gu J, Kelly J, Kemp B, Khuri F, Kurie J, Lee JJ, Lee JS, Liao Z, Merritt J, Morice R, Morello F, Mosheim M, Munden R, Papadoupolous V, Pisters K, Jr PJ, Sarabia AJ, Shelton T, Stevens C, Shin D, Smythe WR, Vaporciyan AA, Walsh GL, Yin M, Yver A. Induction of pro-apoptotic mediators and tumor regression following intratumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy in patients with non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 20:257a, 2001. e-Pub 2001.
216. Swisher SG, Ajani JA, Komaki RR, Walsh GL, Nesbitt JC, Martin FD, Lahoti S, Smythe WR, Vaporciyan AA, Putnam JB, Roth JA. Improved long-term survival in esophageal cancer following the novel strategy of induction chemotherapy prior to concurrent chemoradiation and surgery. Proc. West. Thorac. Surg. Assoc 66:22, 2001. e-Pub 2001.
217. Ito I, Saeki T, Mohiuddin I, Branch CD, Saito Y, Stephens LC, Vaporciyan A, Templeton N, Roth JA, Ramesh R. Persistent gene expression in lung tumor bearing mice but not in non-tumor bearing mice after DOTAP:cholesterol-DNA:liposome complex treatment. Proc. Am. Assoc. Cancer Res 43:31-32, 2001. e-Pub 2001.
218. Ajani J, Komaki R, Walsh GL, Jr PJ, Swisher SG, Lahoti S, Ho L, Faust J, Roe J, Smythe WR, Vaporciyan AA, Pisters P, Kelly J, Stevens C, Roth JA. CPT-11 plus cisplatin as induction chemotherapy followed by chemoradiation in respectable carcinoma of the esophagus and GE Junction (EC-GEJC). Proc. Am. Soc. Clin. Oncol 20:131a, 2001. e-Pub 2001.
219. Vaporciyan AA, Mohiuddin I, Sharma C, Ali A, Yang D, Jr PJ. Neutrophil Depletion Reduces Lung Injury After Isolated Lung Perfusion for Pulmonary Metastasis. Proc. Am. Coll. Surg, 2001. e-Pub 2001.
220. Swisher SG, Wynn P, Mosheim MB, Jr PJ, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Is surgical salvage indicated for recurrent esophageal tumors following definitive chemoradiation? . Proc. Am. Assoc. Thorac. Surg 146:46, 2001. e-Pub 2001.
221. Swisher SG, Roth JA, Komaki R, Hicks M, Ro J, Dreiling L, Yver AB, Stevens C, Putnam JB, Jr, Smythe WR, Vaporciyan AA, Walsh GL. A phase II trial of adenoviral mediated p53 gene transfer (RPR/INGN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer (NSCLC). Am Soc Clin Oncol 19:461a, 2000. e-Pub 2000.
222. Mohiuddin I, Sharma C, Burnett M, Jr PJ, Vaporciyan AA. Characterization of acute lung injury after isolated lung perfusion with doxorubicin. Chest 118:153S, 2000. e-Pub 2000.
223. Komaki R, Roth JA, Walsh GL, Jr PJ, Swisher SG, Vaporciyan AA, Lee JS, Fossella F, Chasen Mand Cox JD. Multidisciplinary approach for 143 patients with superior sulcus tumors treated at M. D. Anderson Cancer Center. J. Jap. Soc. Thorac. Radiol 12(4):110, 2000. e-Pub 2000.
224. Siegenthaler MP, Pisters KM, Merriman KW, Swisher SG, Roth JA, Walsh GL, Vaporciyan AA, Smythe WR, Putnam JB, Jr. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Proc Soc Thorac Surg, 2000. e-Pub 2000.
225. Walsh GL, Davis BM, Swisher SG, Vaporciyan AA, Smythe WR, Roth JA, Putnam JB, Jr. A single-institution, multidisciplinary approach to primary sarcomas involving the chest wall requiring full thickness resections. Proc Am Assoc Thorac Surg 23:82-83, 2000. e-Pub 2000.
226. Putnam JB, Jr, Benjamin RS, Rha SJ, Walsh GL, Swisher SG, Vaporciyan AA, Smythe WR, Roth JA. Early results of isolated single lung perfusion for treatment of unresectable sarcomatous metastases. Proc Am Assoc Thorac Surg 21:78-79, 2000. e-Pub 2000.
227. Gandhi S, Walsh GL, Komaki R, Gokaslan Z, Jr PJ, Roth JA, Merriman K, Vaporciyan AA, Swisher SG. An Aggressive multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion can lead to long-term survival. Proc. Soc. Thorac. Surg 35:90-91, 1999. e-Pub 1999.
228. Swisher SG, Deford L, Merriman K, Hunt KK, Walsh G, Vaporciyan A, Smythe WR, Morris M, Roth J, Putnam JB, Jr. Impact of operative volume on morbidity, mortality and hospital usage following esophagectomy for esophageal cancer. Proc West Thorac Surg Assoc, 1999. e-Pub 1999.
229. Swisher SG, Hu M, Holmes EC, Hunt K, Ajani J, McFadden D, Nelson S, Nesbitt J, Jr PJ, Vaporciyan AA, Walsh GL, Zinner M, Roth JA. Impact of number of involved lymph nodes on long-term survival in esophageal cancer. Cancer Symposium 51:64-64, 1998. e-Pub 1998.
230. Komaki R, Perkins P, Allen P, Vaporciyan AA, Cox JD. Multidisciplinary approach for the management of superior sulcus tumors. Proc. Am. Soc. Clinic. Oncol 17:491a-491a, 1998. e-Pub 1998.
231. Jones ML, Vaporciyan AA, Bonish BK, Ward PA. In vitro and in vivo regulation of ICAM-1 and MCP-1 expression by interleukin-10. J. Cell. Biochem., Abstract supplement:317, 1994. e-Pub 1994.
232. Vaporciyan AA, Albelda SM, Ward PA. Neutrophil recruitment in vivo is platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) dependent. Intensive Care Medicine 20:S40 (#157), 1994. e-Pub 1994.
233. Vaporciyan AA, Ward PA. Enhancement of human neutrophil generation of O2-is via a complement iC3b/Mac-1 interaction. FASEB J 7:A195 (#1128), 1993. e-Pub 1993.
234. Vaporciyan AA, Mulligan MS, Myasaka M, Tamatani T, Ward PA. Expression of ICAM-1 in vivo in immune complex-mediated alveolitis is TNFa dependent. Journal of Cellular Biochemistry, Abstract supplement 17A:336 (#C117), 1993. e-Pub 1993.
235. Jones ML, Vaporciyan AA, Ward PA. A rapid fluorescent multi-well method for measuring neutrophil and monocyte chemotaxis. FASEB J 7(3):A365 (#2115), 1993. e-Pub 1993.
236. Vaporciyan AA, Jones ML, Ward, PA. Rapid determination of neutrophil to enothelial cell adhesion in vitro using fluorescent labeling of cells. FASEB J 6:#A1821, 1992. e-Pub 1992.